补肾益精法对骨髓间充质干细胞增殖的影响及机理研究
|
摘要
研究目的
在“干细胞具先天之精的属性,是先天之精在细胞层次的存在形式”、“精血同源”等理论的指导下,本研究运用补精生血法、补精滋阴法、补精壮阳法、补气化髓生血法来探讨补肾益精法对骨髓间充质干细胞(MSCs)增殖的影响。把中医药与干细胞研究相结合,为体外培养、扩增MSCs提供新的思路,为中医药干预临床干细胞移植治疗疾病提供有力的实验依据。
在药物筛选的基础上,观察对MSCs增殖确有促进作用的中药单体、有效成分及含药血清对细胞因子表达的影响,分析它们可能的作用途径,为阐释其促进MSCs增殖的作用机理提供实验依据,将补肾益精法对MSCs增殖影响的研究深入到分子水平,也为“精”的干细胞学说提供了更充分的科学依据。
研究方法
1.运用全骨髓贴壁法分离、培养MSCs;通过形态学、流式细胞仪检测表面标志物鉴定MSCs。
2.运用MTT法筛选对MSCs增殖具有促进作用的益精中药的单体、有效成分及含药血清,并研究其最佳促增殖时间、浓度。
3.用黄芪多糖(APS)及其含药血清、二苯乙烯苷(THSG)及何首乌含药血清诱导培养MSCs 72h后,RT-PCR检测不同细胞因子mRNA表达；Real-time PCR检测SCF mRNA表达；western blot检测SCF蛋白表达；ELISA法检测培养上清液SCF含量。
4.用黄精含药血清诱导培养MSCs 72h后,RT-PCR检测不同细胞因子mRNA表达：Real-time PCR检测G-CSF mRNA表达；western blot检测G-CSF蛋白表达。
5.用菟丝子含药血清诱导培养MSCs 72h后,RT-PCR检测不同细胞因子mRNA表达；Real-time PCR检测BMP-2 mRNA表达；western blot检测BMP-2蛋白表达。
6.用巴戟天多糖诱导培养MSCs 72h后,RT-PCR检测不同细胞因子mRNA表达；Real-time PCR检测LIF. GM-CSF mRNA表达：western blot检测LIF、GM-CSF蛋白表达。
7.用3月龄SD雌性大鼠双侧卵巢切除增龄3月法复制肾虚模型；选用补肾益精代表方左归丸对模型大鼠灌胃。
8.观察证常组、模型组、左归丸组大鼠MSCs细胞形态、细胞表面标志物测定、生长曲线、β-半乳糖苷酶衰老细胞染色结果,比较各组大鼠MSCs增殖能力。运用RT-PCR检测正常组、模型组、左归丸组MSCs增殖过程中不同细胞因子mRNA表达。
9.通过观察正常组、模型组、左归丸组大鼠MSCs在成骨细胞分化过程中ALP活性的表达、ALP染色阳性细胞率,比较各组大鼠MSCs的成骨细胞分化能力。
10.通过观察正常组、模型组、左归丸组大鼠MSCs在成脂细胞分化过程中TG的表达、油红O染色阳性细胞率,比较各组大鼠MSCs的成脂细胞分化能力。
结果
1.建立了比较成熟的SD大鼠MSCs的分离、纯化、扩增技术平台,免疫荧光染色法和流式细胞仪检测大鼠MSCs表面标志抗原CD44、CD29表达阳性,CD45、CD34表达阴性。
2.10-1mol/L THSG、10%何首乌含药血清诱导培养MSCs72h后,可促进MSCs增殖,在此过程中,均明显促进细胞SCF mRNA表达,与空白组、空白血清组相比有显著性差异。10mol/LTHSG明显促进膜结合型与可溶性两种SCF蛋白表达,10%何首乌含药血清明显促进可溶性SCF蛋白的分泌,与空白组、空白血清组相比有显著性差异。
3.10%黄精含药血清诱导培养MSCs 72h后,可促进MSCs增殖,在此过程中,明显促进细胞G-CSF mRNA及G-CSF蛋白表达,与空白血清组相比有显著性差异。
4. lmg/mL巴戟天多糖、10%菟丝子含药血清诱导培养MSCs 72h后,可促进MSCs增殖。在此过程中,lmg/mL巴戟天多糖明显促进细胞LIF、GM-CSF mRNA及LIF蛋白表达,10%菟丝子含药血清明显促进细胞BMP-2 mRNA表达,与空白组、空白血清组相比有显著性差异。
5. lmg/mL APS、10%APS含药血清诱导培养MSCs 72h后,可促进MSCs增殖,在此过程中,均明显促进细胞SCF mRNA表达,与空白组、空白血清组相比有显著性差异。lmg/mL APS明显促进膜结合型与可溶性两种SCF蛋白表达,10%APS含药血清明显促进可溶性SCF蛋白的分泌,与空白组、空白血清组相比有显著性差异。
6.正常组、模型组、左归丸组大鼠MSCs表面标志物测定的结果显示,单位体积内的原代骨髓单个核细胞中,模型组CD34阴性细胞比率明显高于正常组,有显著性差异：且CD105阳性细胞比率有低于正常组的趋势。从P3、P5代MSCs生长曲线图均可发现,模型组大鼠MSCs增殖能力较正常组、左归丸组明显降低,有显著性差异。β-半乳糖苷酶染色结果显示,模型组衰老细胞阳性率最高,明显高于正常组,有显著性差异。
7.与正常组相比,模型组MSCs在增殖过程中,GM-CSF、LIF、CSF、BMP-2 mRNA表达明显降低,有显著性差异。
8.骨向诱导18、21d时,模型组、左归丸组MSCs ALP表达量明显低于正常组,有显著性差异。14d开始,模型组、左归丸组大鼠MSCs的ALP染色阳性率明显低于正常组,有统计学意义。脂向诱导14d开始,模型组、左归丸组大鼠MSCs的脂肪细胞阳性率明显高于正常组,有显著性差异。
结论
1.采用全骨髓贴壁法可获得稳定、均质性良好的大鼠MSCs。
2.10-1mol/L THSG可促进MSCs增殖,可能与其促进细胞SCF mRNA、膜结合型与可溶性两种SCF蛋白表达有关。10%何首乌含药血清可促进MSCs增殖,可能与其促进细胞SCF mRNA及可溶性SCF蛋白表达有关。
3.10%黄精含药血清促进MSCs增殖的作用,可能与其促进细胞G-CSF mRNA及G-CSF蛋白表达有关。
4.10%菟丝子含药血清促进MSCs增殖的作用,可能与其促进细胞BMP-2 mRNA表达有关。lmg/mL巴戟天多糖促进MSCs增殖的作用,可能与其促进细胞LIF、GM-CSF mRNA及LIF蛋白表达有关。
5. lmg/mL APS可促进MSCs增殖,可能与其促进细胞SCF mRNA、膜结合型与可溶性两种SCF蛋白表达有关。10%APS含药血清可促进MSCs增殖,可能与其促进细胞SCFmRNA及可溶性SCF蛋白表达有关。
6.去卵巢大鼠MSCs增殖能力减弱,可能与其表达GM-CSF、LIF、CSF、BMP-2 mRNA表达减少有关。补肾益精代表方左归丸对肾虚大鼠MSCs增殖能力的改善有一定的作用。
7.去卵巢大鼠MSCs骨向分化能力降低,脂向分化能力增强。
Research purpose and sense
According to "essence and blood have the same source" and "stem cells have the same properties as congenital essence", we use these methods of nourishing essence and promoting blood, nourishing essence and fostering yin, nourishing essence and enriching yang, invigorating qi and manufacturing marrow to transforming blood, to study the effect of invigorating kidney and nourishing essence on mesenchymal stem cells (MSCs) proliferation in vitro. Combining traditional chinese medicine and stem cell research can provide new ideas for culture and amplification of MSCs in vitro, and provide strong experimental evidence for assisting clinical stem cell transplantation for treatment of diseases by Chinese medicine.
On the basis of drug screening, we observed the influence of traditional Chinese medicine monomer, active ingredients and medicated serum which is useful for the promotion of MSCs on cytokine expression, to analyze their possible pathway. It can provide experimental basis for explaining its mechanism of promoting proliferation of MSCs, furnish more adequate scientific basis for the "essence" of the stem cell theory, and this study will be improved to the level of molecular.
Research methods
1. MSCs was isolated and purified by whole bone marrow adherent method; MSCs was identified by morphologic characteristics, surface antigens detected with flow cytometer.
2. The effect of nourishing essence herbs-induced proliferation on MSCs was detected by MTT,it help us to judge which traditional Chinese medicine can promote proliferation of MSCs and to study its best time, concentration for promoting proliferation.
3. To cultivate MSCs 72h by medium of APS and its medicated serum, medium of THSG and polygonum multiflorum medicated serum, different cytokine mRNA expression were detected by RT-PCR, SCF mRNA expression was detected by Real-time PCR;SCF protein expression was detected by western blot;SCF content of supernatant was detected by ELISA.
4. To cultivate MSCs 72h by polygonatum medicated serum, different cytokine mRNA expression were detected by RT-PCR, G-CSF mRNA expression was detected by Real-time PCR;G-CSF protein expression was detected by western blot.
5. To cultivate MSCs 72h by dodder medicated serum,different cytokine mRNA expression were detected by RT-PCR, BMP-2 mRNA expression was detected by Real-time PCR;BMP-2 protein expression was detected by western blot.
6. To cultivate MSCs 72h by medium of morinda officinalis polysaccharide, different cytokine mRNA expression were detected by RT-PCR, LIF、GM-CSF mRNA expression were detected by Real-time PCR;LIF、GM-CSF protein expression were detected by western blot.
7. The weak kidney animal model was established by ovariectomy on female Sprague-Dawley (SD) rats aged 3 month;some model animal were fed with zuo gui pill.
8. To investigate MSCs proliferation capacity of normal group, model group, and zuo gui pill group by comparing results of morphologic characteristics, surface antigens andβ-galactosidase staining senescent cells of differernt groups;different cytokine mRNA expression in the course of MSCs proliferation of differernt groups were detected by RT-PCR.
9. To investigate differentiation capacity into osteoblasts of normal group, model group, and zuo gui pill group by compairing the expression of alkaline phosphatase (ALP) activity and the number of ALP stained positive cells.
10. To investigate differentiation capacity into steatoblast of normal group, model group, and zuo gui pill group by compairing the expression of triglyeride (TG) and the number of oil red stained positive cells.
Results
1. We established a mature separation, purification, amplification technology platform of SD rat MSCs. The results of the surface antigens of MSCs detected by immunofluorescence and flow cytometer showed the positive expressions of CD29、CD44 and the negative expressions of CD34、CD45.
2.10-1mol/L THSG、10% polygonum multiflorum medicated serum can significantly promote the proliferation of MSCs, and significantly promote SCF mRNA expression.10-1mol/L THSG significantly promote membrane binding and soluble SCF protein expression,10% polygonum multiflorum medicated serum significantly promote soluble SCF protein secretion.
3.10% polygonatum medicated serum can significantly promote the proliferation of MSCs, and significantly promote G-CSF mRNA and G-CSF protein expression.
4.1mg/mL morinda officinalis polysaccharide and 10% dodder medicated serum can significantly promote the proliferation of MSCs. 1mg/mL Morinda officinalis polysaccharide significantly promote LIF、GM-CSF mRNA and LIF protein expression.10% dodder medicated serum significantly promote BMP-2 mRNA expression.
5.1mg/mL APS、10% APS medicated serum can significantly promote the proliferation of MSCs, and significantly promote SCF mRNA expression. 1mg/mL APS significantly promote membrane binding and soluble SCF protein expression, 10% APS medicated serum significantly promote soluble SCF protein secretion.
6. Unit volume of primary bone marrow mononuclear cells, the number of CD34 negative cells in model group was significantly higher than normal group, and there was a trend that the number of CD105 positive cells in model group lower than normal group. From growth curve of P3、P5 MSCs, the proliferation capacity of MSCs in model group was significantly lower than normal group and Zuo gui pill group;β-galactosidase staining showed that the model group had the highest positive rate of aging cells, significantly higher than the normal group.
7. In the proliferation process of MSCs, GM-CSF, LIF, CSF, BMP-2 mRNA expression of model group was significantly lower than normal group.
8. On 18、21d of differentiating into osteoblasts, MSCs ALP expression of normal group was significantly higher than model group,Zuo gui pill group. From 14d, the rate of ALP stained positive cells of model group and Zuo gui pill group MSCs was significantly lower than normal group. From 14d of differentiating into steatoblast, the rate of oil red stained positive cells of model group and Zuo gui pill group MSCs was significantly higher than normal group.
Conclusion
1. The stable and uniformal MSCs could be obtained by whole bone marrow adherent method.
2. 10-4mol/L THSG can promote the proliferation of MSCs, and it may be related to the promotion of SCF mRNA、membrane binding and soluble SCF protein expression.10% polygonum multiflorum medicated serum can promote the proliferation of MSCs, and it may be related to the promotion of SCF mRNA and soluble SCF protein expression.
3.10% polygonatum medicated serum can promote the proliferation of MSCs, and it may be related to the promotion of G-CSF mRNA and G-CSF protein expression.
4.10% dodder medicated serum can promote the proliferation of MSCs, and it may be related to the promotion of BMP-2 mRNA expression. lmg/mL morinda officinalis polysaccharide can promote the proliferation of MSCs may be related to the promotion of LIF、GM-CSF mRNA and LIF protein expression.
5. lmg/mL APS can promote the proliferation of MSCs, and it may be related to the promotion of SCF mRNA、membrane binding and soluble SCF protein expression.10% APS medicated serum can promote the proliferation of MSCs, and it may be related to the promotion of SCF mRNA and soluble SCF protein expression.
6. The decreased proliferation capacity of MSCs from ovariectomized rats might be associated with the decreased expression of GM-CSF、LIF、CSF、BMP-2 mRNA. To some extent, Zuo gui pill can improve proliferation capacity of weak kidney rats MSCs.
7. Compared with normal rats MSCs, the ability of differentiation into osteoblast of MSCs from ovariectomized rats increased, and the ability of differentiation into adipocytes of MSCs reduced.
在“干细胞具先天之精的属性,是先天之精在细胞层次的存在形式”、“精血同源”等理论的指导下,本研究运用补精生血法、补精滋阴法、补精壮阳法、补气化髓生血法来探讨补肾益精法对骨髓间充质干细胞(MSCs)增殖的影响。把中医药与干细胞研究相结合,为体外培养、扩增MSCs提供新的思路,为中医药干预临床干细胞移植治疗疾病提供有力的实验依据。
在药物筛选的基础上,观察对MSCs增殖确有促进作用的中药单体、有效成分及含药血清对细胞因子表达的影响,分析它们可能的作用途径,为阐释其促进MSCs增殖的作用机理提供实验依据,将补肾益精法对MSCs增殖影响的研究深入到分子水平,也为“精”的干细胞学说提供了更充分的科学依据。
研究方法
1.运用全骨髓贴壁法分离、培养MSCs;通过形态学、流式细胞仪检测表面标志物鉴定MSCs。
2.运用MTT法筛选对MSCs增殖具有促进作用的益精中药的单体、有效成分及含药血清,并研究其最佳促增殖时间、浓度。
3.用黄芪多糖(APS)及其含药血清、二苯乙烯苷(THSG)及何首乌含药血清诱导培养MSCs 72h后,RT-PCR检测不同细胞因子mRNA表达；Real-time PCR检测SCF mRNA表达；western blot检测SCF蛋白表达；ELISA法检测培养上清液SCF含量。
4.用黄精含药血清诱导培养MSCs 72h后,RT-PCR检测不同细胞因子mRNA表达：Real-time PCR检测G-CSF mRNA表达；western blot检测G-CSF蛋白表达。
5.用菟丝子含药血清诱导培养MSCs 72h后,RT-PCR检测不同细胞因子mRNA表达；Real-time PCR检测BMP-2 mRNA表达；western blot检测BMP-2蛋白表达。
6.用巴戟天多糖诱导培养MSCs 72h后,RT-PCR检测不同细胞因子mRNA表达；Real-time PCR检测LIF. GM-CSF mRNA表达：western blot检测LIF、GM-CSF蛋白表达。
7.用3月龄SD雌性大鼠双侧卵巢切除增龄3月法复制肾虚模型；选用补肾益精代表方左归丸对模型大鼠灌胃。
8.观察证常组、模型组、左归丸组大鼠MSCs细胞形态、细胞表面标志物测定、生长曲线、β-半乳糖苷酶衰老细胞染色结果,比较各组大鼠MSCs增殖能力。运用RT-PCR检测正常组、模型组、左归丸组MSCs增殖过程中不同细胞因子mRNA表达。
9.通过观察正常组、模型组、左归丸组大鼠MSCs在成骨细胞分化过程中ALP活性的表达、ALP染色阳性细胞率,比较各组大鼠MSCs的成骨细胞分化能力。
10.通过观察正常组、模型组、左归丸组大鼠MSCs在成脂细胞分化过程中TG的表达、油红O染色阳性细胞率,比较各组大鼠MSCs的成脂细胞分化能力。
结果
1.建立了比较成熟的SD大鼠MSCs的分离、纯化、扩增技术平台,免疫荧光染色法和流式细胞仪检测大鼠MSCs表面标志抗原CD44、CD29表达阳性,CD45、CD34表达阴性。
2.10-1mol/L THSG、10%何首乌含药血清诱导培养MSCs72h后,可促进MSCs增殖,在此过程中,均明显促进细胞SCF mRNA表达,与空白组、空白血清组相比有显著性差异。10mol/LTHSG明显促进膜结合型与可溶性两种SCF蛋白表达,10%何首乌含药血清明显促进可溶性SCF蛋白的分泌,与空白组、空白血清组相比有显著性差异。
3.10%黄精含药血清诱导培养MSCs 72h后,可促进MSCs增殖,在此过程中,明显促进细胞G-CSF mRNA及G-CSF蛋白表达,与空白血清组相比有显著性差异。
4. lmg/mL巴戟天多糖、10%菟丝子含药血清诱导培养MSCs 72h后,可促进MSCs增殖。在此过程中,lmg/mL巴戟天多糖明显促进细胞LIF、GM-CSF mRNA及LIF蛋白表达,10%菟丝子含药血清明显促进细胞BMP-2 mRNA表达,与空白组、空白血清组相比有显著性差异。
5. lmg/mL APS、10%APS含药血清诱导培养MSCs 72h后,可促进MSCs增殖,在此过程中,均明显促进细胞SCF mRNA表达,与空白组、空白血清组相比有显著性差异。lmg/mL APS明显促进膜结合型与可溶性两种SCF蛋白表达,10%APS含药血清明显促进可溶性SCF蛋白的分泌,与空白组、空白血清组相比有显著性差异。
6.正常组、模型组、左归丸组大鼠MSCs表面标志物测定的结果显示,单位体积内的原代骨髓单个核细胞中,模型组CD34阴性细胞比率明显高于正常组,有显著性差异：且CD105阳性细胞比率有低于正常组的趋势。从P3、P5代MSCs生长曲线图均可发现,模型组大鼠MSCs增殖能力较正常组、左归丸组明显降低,有显著性差异。β-半乳糖苷酶染色结果显示,模型组衰老细胞阳性率最高,明显高于正常组,有显著性差异。
7.与正常组相比,模型组MSCs在增殖过程中,GM-CSF、LIF、CSF、BMP-2 mRNA表达明显降低,有显著性差异。
8.骨向诱导18、21d时,模型组、左归丸组MSCs ALP表达量明显低于正常组,有显著性差异。14d开始,模型组、左归丸组大鼠MSCs的ALP染色阳性率明显低于正常组,有统计学意义。脂向诱导14d开始,模型组、左归丸组大鼠MSCs的脂肪细胞阳性率明显高于正常组,有显著性差异。
结论
1.采用全骨髓贴壁法可获得稳定、均质性良好的大鼠MSCs。
2.10-1mol/L THSG可促进MSCs增殖,可能与其促进细胞SCF mRNA、膜结合型与可溶性两种SCF蛋白表达有关。10%何首乌含药血清可促进MSCs增殖,可能与其促进细胞SCF mRNA及可溶性SCF蛋白表达有关。
3.10%黄精含药血清促进MSCs增殖的作用,可能与其促进细胞G-CSF mRNA及G-CSF蛋白表达有关。
4.10%菟丝子含药血清促进MSCs增殖的作用,可能与其促进细胞BMP-2 mRNA表达有关。lmg/mL巴戟天多糖促进MSCs增殖的作用,可能与其促进细胞LIF、GM-CSF mRNA及LIF蛋白表达有关。
5. lmg/mL APS可促进MSCs增殖,可能与其促进细胞SCF mRNA、膜结合型与可溶性两种SCF蛋白表达有关。10%APS含药血清可促进MSCs增殖,可能与其促进细胞SCFmRNA及可溶性SCF蛋白表达有关。
6.去卵巢大鼠MSCs增殖能力减弱,可能与其表达GM-CSF、LIF、CSF、BMP-2 mRNA表达减少有关。补肾益精代表方左归丸对肾虚大鼠MSCs增殖能力的改善有一定的作用。
7.去卵巢大鼠MSCs骨向分化能力降低,脂向分化能力增强。
Research purpose and sense
According to "essence and blood have the same source" and "stem cells have the same properties as congenital essence", we use these methods of nourishing essence and promoting blood, nourishing essence and fostering yin, nourishing essence and enriching yang, invigorating qi and manufacturing marrow to transforming blood, to study the effect of invigorating kidney and nourishing essence on mesenchymal stem cells (MSCs) proliferation in vitro. Combining traditional chinese medicine and stem cell research can provide new ideas for culture and amplification of MSCs in vitro, and provide strong experimental evidence for assisting clinical stem cell transplantation for treatment of diseases by Chinese medicine.
On the basis of drug screening, we observed the influence of traditional Chinese medicine monomer, active ingredients and medicated serum which is useful for the promotion of MSCs on cytokine expression, to analyze their possible pathway. It can provide experimental basis for explaining its mechanism of promoting proliferation of MSCs, furnish more adequate scientific basis for the "essence" of the stem cell theory, and this study will be improved to the level of molecular.
Research methods
1. MSCs was isolated and purified by whole bone marrow adherent method; MSCs was identified by morphologic characteristics, surface antigens detected with flow cytometer.
2. The effect of nourishing essence herbs-induced proliferation on MSCs was detected by MTT,it help us to judge which traditional Chinese medicine can promote proliferation of MSCs and to study its best time, concentration for promoting proliferation.
3. To cultivate MSCs 72h by medium of APS and its medicated serum, medium of THSG and polygonum multiflorum medicated serum, different cytokine mRNA expression were detected by RT-PCR, SCF mRNA expression was detected by Real-time PCR;SCF protein expression was detected by western blot;SCF content of supernatant was detected by ELISA.
4. To cultivate MSCs 72h by polygonatum medicated serum, different cytokine mRNA expression were detected by RT-PCR, G-CSF mRNA expression was detected by Real-time PCR;G-CSF protein expression was detected by western blot.
5. To cultivate MSCs 72h by dodder medicated serum,different cytokine mRNA expression were detected by RT-PCR, BMP-2 mRNA expression was detected by Real-time PCR;BMP-2 protein expression was detected by western blot.
6. To cultivate MSCs 72h by medium of morinda officinalis polysaccharide, different cytokine mRNA expression were detected by RT-PCR, LIF、GM-CSF mRNA expression were detected by Real-time PCR;LIF、GM-CSF protein expression were detected by western blot.
7. The weak kidney animal model was established by ovariectomy on female Sprague-Dawley (SD) rats aged 3 month;some model animal were fed with zuo gui pill.
8. To investigate MSCs proliferation capacity of normal group, model group, and zuo gui pill group by comparing results of morphologic characteristics, surface antigens andβ-galactosidase staining senescent cells of differernt groups;different cytokine mRNA expression in the course of MSCs proliferation of differernt groups were detected by RT-PCR.
9. To investigate differentiation capacity into osteoblasts of normal group, model group, and zuo gui pill group by compairing the expression of alkaline phosphatase (ALP) activity and the number of ALP stained positive cells.
10. To investigate differentiation capacity into steatoblast of normal group, model group, and zuo gui pill group by compairing the expression of triglyeride (TG) and the number of oil red stained positive cells.
Results
1. We established a mature separation, purification, amplification technology platform of SD rat MSCs. The results of the surface antigens of MSCs detected by immunofluorescence and flow cytometer showed the positive expressions of CD29、CD44 and the negative expressions of CD34、CD45.
2.10-1mol/L THSG、10% polygonum multiflorum medicated serum can significantly promote the proliferation of MSCs, and significantly promote SCF mRNA expression.10-1mol/L THSG significantly promote membrane binding and soluble SCF protein expression,10% polygonum multiflorum medicated serum significantly promote soluble SCF protein secretion.
3.10% polygonatum medicated serum can significantly promote the proliferation of MSCs, and significantly promote G-CSF mRNA and G-CSF protein expression.
4.1mg/mL morinda officinalis polysaccharide and 10% dodder medicated serum can significantly promote the proliferation of MSCs. 1mg/mL Morinda officinalis polysaccharide significantly promote LIF、GM-CSF mRNA and LIF protein expression.10% dodder medicated serum significantly promote BMP-2 mRNA expression.
5.1mg/mL APS、10% APS medicated serum can significantly promote the proliferation of MSCs, and significantly promote SCF mRNA expression. 1mg/mL APS significantly promote membrane binding and soluble SCF protein expression, 10% APS medicated serum significantly promote soluble SCF protein secretion.
6. Unit volume of primary bone marrow mononuclear cells, the number of CD34 negative cells in model group was significantly higher than normal group, and there was a trend that the number of CD105 positive cells in model group lower than normal group. From growth curve of P3、P5 MSCs, the proliferation capacity of MSCs in model group was significantly lower than normal group and Zuo gui pill group;β-galactosidase staining showed that the model group had the highest positive rate of aging cells, significantly higher than the normal group.
7. In the proliferation process of MSCs, GM-CSF, LIF, CSF, BMP-2 mRNA expression of model group was significantly lower than normal group.
8. On 18、21d of differentiating into osteoblasts, MSCs ALP expression of normal group was significantly higher than model group,Zuo gui pill group. From 14d, the rate of ALP stained positive cells of model group and Zuo gui pill group MSCs was significantly lower than normal group. From 14d of differentiating into steatoblast, the rate of oil red stained positive cells of model group and Zuo gui pill group MSCs was significantly higher than normal group.
Conclusion
1. The stable and uniformal MSCs could be obtained by whole bone marrow adherent method.
2. 10-4mol/L THSG can promote the proliferation of MSCs, and it may be related to the promotion of SCF mRNA、membrane binding and soluble SCF protein expression.10% polygonum multiflorum medicated serum can promote the proliferation of MSCs, and it may be related to the promotion of SCF mRNA and soluble SCF protein expression.
3.10% polygonatum medicated serum can promote the proliferation of MSCs, and it may be related to the promotion of G-CSF mRNA and G-CSF protein expression.
4.10% dodder medicated serum can promote the proliferation of MSCs, and it may be related to the promotion of BMP-2 mRNA expression. lmg/mL morinda officinalis polysaccharide can promote the proliferation of MSCs may be related to the promotion of LIF、GM-CSF mRNA and LIF protein expression.
5. lmg/mL APS can promote the proliferation of MSCs, and it may be related to the promotion of SCF mRNA、membrane binding and soluble SCF protein expression.10% APS medicated serum can promote the proliferation of MSCs, and it may be related to the promotion of SCF mRNA and soluble SCF protein expression.
6. The decreased proliferation capacity of MSCs from ovariectomized rats might be associated with the decreased expression of GM-CSF、LIF、CSF、BMP-2 mRNA. To some extent, Zuo gui pill can improve proliferation capacity of weak kidney rats MSCs.
7. Compared with normal rats MSCs, the ability of differentiation into osteoblast of MSCs from ovariectomized rats increased, and the ability of differentiation into adipocytes of MSCs reduced.
引文
[1]Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science,1999; 284(5411):143-147.
[2]郭艳,史大卓,陈可冀.中医药结合干细胞移植治疗心肌损伤性疾病的前景.新中医,2005；37(5)：88-89.
[3]张进,徐志伟,杜少辉,等.“精”学说与干细胞辨识.中医药学刊,2004；22(7)：1198-1200.
[4]张进,徐志伟,陈群,等.干细胞与中医基础理论中的先天之精学说.中国临床康复,2006：10(7)：189-192.
[5]张进,徐志伟.补肾法诱导间充质干细胞向神经方向分化研究.现代医院,2004；4(9)：15-17.
[1]Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell:entity or function?. Cell,2001; 105(7):829-841.
[2]Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries?. Nat Med, 2001; 7(4):393-395.
[3]Verfaillie CM, Pera MF, Lansdorp PM. Stem cells:hype and reality. Hematology Am Soc Hematol Educ Program,2002:369-391.
[4]Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science,1998; 282 (5391):1145-1147.
[5]Shamblott MJ, Axelman J, Wang SP, et al. Derivation of plutipotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA,1998; 95(23):13726-13731.
[6]Thomson JA. Embryonic stem cell lines derived from human blastocysts. Science,1998; 282(6):1145-1147.
[7]王启凤,王锋,蔡夸波.胚胎干细胞的研究进展及其应用.畜牧与兽医,2002；34(2)：40-42.
[8]Yamashita J, Itoh H, Hirashima M, et al. Flk-1 positive cells derived from embryonic stem cells serve as vascular progenitors. Nature,2000; 408(6808):92-96.
[9]Rolletschek A, Blyszczuk P, Wobus AM. Embryonic stem cell-derived cardiac, neuronal and pancreatic cells as model systems to study toxicological effects. Toxicol Lett, 2004; 149(1-3):361-369.
[10]Zur Nieden NI, Kempka G, Ahr HJ. In vitro diferentiation of embryoni stem cells into mineralized osteoblasts. Differentiation,2003; 71(1):18-27.
[11]Harper JM, Kfishnan C, Darman JS, et al. Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci USA,2004; 101(18):7123-7128.
[12]Zandstra PW,Bauwens C, Yin T, et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng,2003; 9(4):767-778.
[13]Kim D, Gu Y, Ishii M, et al. In vivo functioning and transplantable mature pancreatic islet-like cell clusters differentiated from embryonic stem cell. Pancreas,2003; 27(2): 34-41.
[14]赵惠萍,卢光锈,王绮如.两种条件培养基促进鼠胚胎干细胞分化为造血干细胞.中南大学学报,2007；32(1)：64-67.
[15]熊吉信,刘兆轩,刘小春,等.体外定向诱导小鼠胚胎干细胞向内皮细胞分化的研究.中国修复重建外科杂志,2007121(9)：994-996.
[16]Hubner K, Fuhrmann G, Christenson LK, et al. Derivation of oocytes from mouse Embryonic stem cells. Science,2003; 300(5623):1251-1256.
[17]Koay EJ, Hoben GM, Athanasiou KA, et al. Tissue engineering with chondrogenically differentiated human embryonic stem cells. Stem Cells,2007; 25(9):2183-2190.
[18]Lindvall 0. Stem cells for cell therapy in Parkinson disease. Pharmacol Res,2003; 47(4):279-287.
[19]McDonaid JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med,1999; 5(12): 1410-1412.
[20]Kim JH, Auerliacch JM, Rodriguez Gomez JA, et al. Dopamine ueurons derived from embryonic stem cells funetion in all animal model of Parkinson'sdisease. Nature,2002; 418(6983):50-56.
[21]Cho YH, Kim DS, Kim PG, et al. Dopamine neurons derived from embryonic stem cells efficiently induce behavioral recovery in a Parkinsonian rat model. Bioehem Biophys RESC Commun,2006; 341(1):6-12.
[22]Min JY, Yang YK, Converse KL, et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol,2002; 92(1): 288-296.
[23]Laf lamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology,2007; 25(9):1015-1024.
[24]周其峰,何志旭,冯炼强,等.用胚胎干细胞诱导的造血干／祖细胞重建小鼠造血功能研究.热带医学杂志,2003；3(1)：9-11.
[25]Soria B, Roche E, Bema G, et al. Insulin-secreting cells derived from embryonic stem cells normaliz ESC glycerin in streptozotocin-induced diabetic mice. Diabet ESC,2000; 49(2):157-162.
[26]胡安斌,何晓顺,郑启昌,等.胚胎干细胞来源的肝细胞对急性肝功能衰竭小鼠的移植治疗作用.中华医学杂志,2006；86(46)：3281-3284.
[27]Burke ZD, Tosh D. Therapeutic potential of trailsdiferentiated cells. Clin Sci (Lond), 2005,108:309-321.
[28]Yang LY, Zheng JK, Wang CY, et al. Differentiation of adult human bone marrow mesenchymal stem cells into schwann-like cells in vitro. Chin J Traumatol,2005; 8(2): 77-80.
[29]Bianco P, Robey PG. Stem cells in tissue engineering. Nature,2001; 414(6859): 118-121.
[30]Coai S, Locateli F, Papadimitriou D, et al. Nuclear reprogramming and adult stem cell potential. Histol Histopathol,2005; 20(3):977-986.
[31]Lemoli RM, Bertolini F, Caneedda R, et al. Stem cell plasticity:time for a reappraisal?. Haematologica,2005; 90(3):360-381.
[32]Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors:stem cells and their niche. Cell,2004; 116(6):769-778.
[33]Pittenger M, Vanguri P, Simonetti D, et al. Adult mesenchymal stem cells:potential for muscle and tendon regeneration and use in gene therapy. J Musculoskelet Neuronal Interact,2002; 2(4):309-320.
[34]Cho KJ, Trzaska KA, Greco SJ, et al. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells,2005; 23(3):383-391.
[35]Doyonnas R, Iabmge MA, Sacco A. Hematopoietic contribution to skeletalmuscle regeneration by myelomonocytic precursors. Proc Natl Acad Sci USA,2004; 101(37): 13507-13512.
[36]Suzuki H, Taguchi T, TanakaH, et al. Neurezpheres induced from bone marrow stromal cells are multipotent for differentiation into neuron, astrocyte and oligodendrocyte phenotypes. Biochem Biophys Res Commun,2004; 322(3):918-922.
[37]杨慧敏,王顺和.神经干细胞定向分化为少突胶质细胞的实验研究.重庆医科大学学报,2007；32(8)：812-816.
[38]郭立达,王捷,夏冰．成体干细胞的可塑性研究.广东医学,2005；26(11)：1588-1590.
[39]Vescovi AL, RietzeR, Magli MC, et al. Hematopoietic potential of neural stem cells. Nat Med,2002; 8(6):535-537.
[40]Toma JG, Akhavan M, Fernandez KJ. Isolation of multipotent adult stem cells from the dermis of mamnlalian skin. Nat Cell Biol,2001; 3(9):778-784.
[41]Peterson B, Zhang J, lglesiasR, et al. Healing of critically sized femoral defects, using genetically modif-ied mezenchymal stem cells from human adipose tissue. Tissue Eng, 2005; 11(1-2):120-129.
[42]Ye F, Duvilie B, Scharfmann R. Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells. Diabetologia,2005; 48(2):277-281.
[43]Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation,2002; 105(1):93-98.
[44]Zuk PA, Zhu M, Mizuno H. Multilineage cells from human adipose tissue:implications for cell-based therapies. Tissue Eng,2001; 7(2):211-228.
[45]Lindberg K, Brown ME, Chavez HV, et al. In vitro propagation of human ocular surface epithelial cells for transplantation. Invest Ophthalmol Vis Sci,1993; 34(9):2672-2679.
[46]Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol,2005; 18(9):959-963.
[47]Yoon E, Dhar S, Chun DE, et al. In vivo osteogenie potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Engineering,2007; 13(3):619-627.
[48]Honma T, Homnou 0, lihoshi S, et al. Intravenous infusion of immaortalized human mesenehymal stem cells protects against iniury in a cerebral ischemia model in adult rat. Exp Neutrml,2006; 199(1):56-66.
[49]Conrad C, Huss R. Adult stem cell lines in regenerative medicine and reconstructive surgery. J Surg Res,2005; 124(2):201-208.
[50]Phinney DG. Lsakova L. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des,2005; 11(10):1255-1265.
[51]Lang D, Lu MM, Huang L, et al. Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature,2005; 433(7028):884-887.
[1]Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietie organs. Exp Hematol,1976; 4(5):267-274.
[2]Caplan AI. Mesenchymal stem cells. J Oflhop Res,1991; 9(5):641-650.
[3]Minguell.JJ, Eriees A, Conget P. Mesenehymal stem cells. Exp Biol Med (Maywod), 2001; 226(6):507-520.
[4]Huss R, Lange C, Weissinger EM, et al. Evidence of peripheral blood derived, plastic adherent CD34 hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells,2000; 18(4):252-260.
[5]Zvailer NJ, Marinova ML, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res,2000; 2(6):477-488.
[6]Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol,2000; 109(1):235-242.
[7]Noort WA, Kruisselbrink AB, Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice. Exp Hematol,2002; 30(8):870-878.
[8]Williams JT, Southerland SS, Souza J, et al. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg,1999; 65(1):22-26.
[9]Almeida PG, EI Shabrawy D, Porada C, et al. Differentiative potential of human metanephric mesenchymal cells. Exp Hematol,2002; 30(12):1454-1462.
[10]Pitenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science,1999; 284(5411):143-147.
[11]Niemeyer P, Seckinger A, Simank HG, et al. Allogenic transplantation of human mesenehymal stem cells for tissue engineering purposes:an in vitro study. Orthopade, 2004; 33(12):1346-1353.
[12]Deans RJ, Moseley AB. Mesenehymal stem cells:biology and potential clinical uses. Exp Hematol,2000,28(8):875-884.
[13]Gang EJ, Bosnakovski D, Figueiredo CA, et al. SSEA-4 identifies mesenchymal stem cells from bone marow. Blood,2007; 109(4):1743-1751.
[14]周进明,邹仲敏,郭朝华,等.小鼠骨髓间质干细胞的生物学特点及分化潜能鉴定.第三军医大学学报,2002；24(1)：58-61.
[15]周进明,邹仲敏,郭朝华,等.培养小鼠骨髓间充质干细胞及其移植后在体内的定位分布.中华放射医学与防护杂志,2002；22(3)：167-169.
[16]Ohgushi H, Caplan Al. Stem cell technology and bioceramics:from cell, to gene engineering. J Bimoed Mater Res,1999; 48(6):913-927.
[17]Conget PA, Minguell JJ. Phenotypical and functional Properties of human bone marow mesenchymal progenitorcells. Cell physiol,1999; 181(1):67-73.
[18]Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem,1997; 64(2):278-294.
[19]Bruder SP, Ricalton NS, Boynton RE, et al. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res,1998; 13(4):655-663.
[20]Hung SC, Chen NJ, Hsieh SL, et al. Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells,2002; 20(3):249-258.
[21]Bartholomew A, Sturgeon C, Siatska M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol,2002; 30(1): 42-48.
[22]Saito T, Kuang JQ, Bittira B, et al. Xenotransplant cardiac chimera:immune tolerance of adult stem cells. Ann Thorac Surg,2002; 74(1):19-24.
[23]Di Nicola M, Carlo SC, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002; 99(10):3838-3843.
[24]Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchyrmal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood, 2003; 101(9):3722-3729.
[25]Van VP, Falla N, Snoeck H, et al. Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using Anti-sca-1 monoclonal antibody and wheat germ agglutinin. Blood,1994; 84(3):753-763.
[26]Encina NR, Billotte WG, Hofmann MC. Immunomagnetic isolation of osteoprogenitors from human bone marrow stroma. Lab Invest,1999; 79(4):449-457.
[27]Woodbury D, Reynolds K, Black IB. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res,2002; 69(6):908-917.
[28]Lu KK, Armstrong SE, Ginnan R, et al. Adhesion-dependent activation of CaMKⅡand regulation of ERK activation in vascular smooth muscle. Am J Physiol Cell Physiol,2005; 289(5):C1343-1350.
[29]Sotiropoulou PA, Perez SA, Salagianni M, et al. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells, 2006; 24(2):462-471.
[30]Wang SJ, Bourguignon LY. Hyaluronan-CD44 promotes phospholipase C mediated Ca2+ signaling and cisplatin resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg,2006; 132(1):19-24.
[31]Stolzing A, Coleman N, Scutt A. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res,2006; 9(1):31-35. [32] Moussavi HF, Duwayri Y, Martin JA, et al. Oxygen effects on senescence in chondrocytes and mesenchymal stem cell:consequences for tissue engineering. Iowa Orthop J,2004; 24:15-20.
[33]Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochern,1997; 64(2):278-294.
[34]Colter DC, Class R, Digirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA, 2000; 97(7):3213-3218.
[35]Pochampally RR, Smith JR, Ylostalo J, et al. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanecd expression of OCT-4 and other embryonic genes. Blood,2004; 103(5):1647-1652.
[36]Qiu Q, Ducheyne P, Gao H, et al. Formation and differentition of three-dimensional rat marrow stromal cell culture on microcarriers in a rotating-wall vessel. Tissue Eng, 1998; 4(1):19-34.
[37]GLowacki J, Mizuno S, Greenberger JS. Perfusion enhances functions of bone marrow stromal cells in three dimensional culture. Cell Transplant,1998; 7(3):319-326.
[38]Kadiyala S, Young RG, Thide MA, et al. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant,1997; 6(2): 125-134.
[39]Nuttall ME, Patten AJ, Oliver DL, et al. Human trabecular bone cells are able to express both osteoblastic and adipocphenotype:implications for osteoponic disorders. J Bone Miner Res,1998; 13(3):371-382.
[40]Pilloni A, Bernard GW. The effect of hyalurmum on mouse intramembranous osteogenesis in vitro. Cell Tissue Res,1998; 294(2):323-333.
[41]Riew KD, Wright NM, Cheng S, et al. Induction of bone formation using are combinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calif Tissue Int,1998; 63(4):357-360.
[42]Mackay AM, Beck SC, Murphy JM, et al. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng,1998; 4(4):415-428.
[43]Rahfoth B, Weisser J, Sternkopf F, et al. Transplantation of allograft chondmcytes embeded in agarose gef into cartilage defects of rabbits. Osteoarthritis Cartilage, 1998; 6(1):50-65.
[44]Worster AA, Nixon AJ, Brower-Toland BD, et al. Effect of transforming growth factor betal on chondrogenic differentiation of cultured equine mesenehymal stem cells. Am J Vet Res,2000; 61(9):1003-1010.
[45]Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve,1995; 18(12):417-426.
[46]Tomita S, Li RK, Weisel RD, et al. Autolagous transplantation of bone marrow cells improves damaged heart function. Circulation,1999; 100(19Suppl):247-256.
[47]Wang JS, Shum Tim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty:feasibility and potential clinical advantages. J Thorac Cardiovasc Surg, 2000; 120(5):999-1005.
[48]Sanchez RJ, Song S, Cardozo PF, et al. Adult bone marrow stromal cells diferenfiate into neural cells in vitro. Exp Neurol,2000; 164(2):247-256.
[49]Kopon GC, Prockop DJ, Phinney IX. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA,1999; 96(19):10711-10716.
[50]Woodburry D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res,2000; 61(4):364-370.
[51]Kohyama J, Abe H, Shimazaki T, et al. Brain from bone:efficient"meta-differentiation" of marrow stromal-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation,2001; 68(4-5):235-244.
[52]Oh SH, Miyazaki M, Kouchi H. Hepatocyte growth factor induces differentiation of adult rat bone marrow cells into a hepatocyte lineage in vitro. Biochem Biophys Res Commun, 2000; 279(2):500-504.
[53]Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest,2002; 109(10): 1291-1302.
[54]Ouyang HW, Cao T, Zou XH, et al. Mesenchymal stem cell sheets revitalize nonviable dense grafts:implications for repair of large-bone and tendon defects. Transplantation, 2006; 82(2):170-174.
[55]朱付平,熊光仲,王万春,等.骨髓间充质干细胞在骨科中应用的研究进展.中国中医骨伤科杂志,2005；13(5)：78-81.
[56]Wakitani S, Imoto K, Yamamoto T, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage,2002; 10(3):199-206.
[57]Ahn JI, Terry Canale S, Butler SD, et al. Stem cell repair of physeal cartilage. J Orthop Res,2004; 22(6):1215-1221.
[58]Murphy JM, Fink DJ, Hunziker EB, et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum,2003; 48(12):3464-3474.
[59]Walsh CJ, Goodman D, Caplan A I, et al. Meniscus regeneration in a rabbit partial meniscectomy model. Tissue Eng,1999; 5(4):327-337.
[60]Brazelton TR, Rossi FMV, Keshet GL, et al. From marrow to brain:expression of neuronal pheno types jn adult mice. Science,2000; 290(5497):1775-1779.
[61]Mezzey E, Chandross KJ, Harta G, et al. Turning blood into brain:cells bearing neuronal antigens generated in vive from bone marrow. Science,2000; 290(5497):1779-1782.
[62]王晔,邓宇斌,那晓东.骨髓间充质干细胞在缺血性脑血管病治疗中的应用.国外医学脑血管疾病分册,2005；13(3)：203-205.
[63]Chen J, Li Y, Zhang R, et al. Combination therapy of stroke in rats with a nitric oxide donor and Human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res,2004; 1005(1-2):21-28.
[64]Park K, Eglitis MA, Mouradian MM. Protection of nigral neurons by GDNF-engineered marrow cells transplantation. Neurosci Res,2001; 40(4):315-323.
[65]胡煜,陈维信,阎影.MSCs在现代细胞治疗中的潜在作用.国际移植与血液净化杂志,2006；4(3)：35-37.
[66]Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci,2001; 938:221-230.
[67]韩永生,褚俊,翟志敏.骨髓间充质干细胞移植治疗心肌梗死的研究进展.国外医学：内科学分册,2004,11(31)：474-477.
[68]Strauer BE, Brehm M, Zeus T, et al. lntracoronary human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr,2001; 126(34-35):932-938.
[69]Tse HF, Kwong YL, Chan JKF, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet,2003; 61(9351):47-49.
[70]Noort WA, Kruisselbrink AB, in't Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+)cells in NOD/SCID mice. Exp Hematol,2002; 30(8):870-878.
[71]Koc ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol,2000; 18(2):307-316.
[72]Lee ST, Jang JH, Cheong JW, et al. Treatment of highrisk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by coinfusion of T cell-depleted haematopo ietic stem cells and culture-expanded marrow mesenchymal stem ceHs from a related donor with one fully mismatched human leucocyte antigen haplotype. BT JHaematol,2002; 118(4): 1128-1131.
[73]施小凤,傅晋翔,李军,等.间充质干细胞联合输注促进造血干细胞移植后的造血重建.中华器官移植杂志,2005；26(7)：411-414.
[74]Kodama S, Kuhtreiber W, Fujimura S, et al. Islet regeneration during reversal of autoimmune diabetes in NOD mice. science,2003; 302(5648):1223-1226.
[75]李立人,徐青.骨髓基质干细胞移植对糖尿病大鼠血糖的影响.苏州大学学报,2005；25(4)：584-585.
[76]Ikebukuro K, Adachi Y, Yamada Y, et al. Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow ceils via portal vein in rats. Transplantation,2002; 73(4):512-518.
[77]张传仓,朱为国,封志纯.自体骨髓干细胞移植治疗1型糖尿病的初步研究.广东医学,2004；25(12)：1398-1399.
[78]Theise ND, Badyes, Saxena R, et al. Derivation of hepatocytes from bone marrow cells in mice-after radiation induced myeloablation. Hepatology,2000; 31(1):235-240.
[79]She-Hoon OH, Heather M, Hatch BE. Hepaticoval stem cell in liver regeneration Seminars in cell and developmental. Biology,2002; 13(6):405-409.
[80]Wang JS, Shunrtim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty:Feasibility and potential clinical advantages. J Tholo Cardiova Surg, 2000; 120(5):999-1005.
[81]李莉,李燕芹.骨髓干细胞在肺纤维化中的作用及治疗.国际呼吸杂志,2006；26(7)：503-505.
[82]Yamada M, Kubo H, Kobayashi S, et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. Immunol,2004; 172(2):1266-1272.
[83]Rojas M, Xu J, Woods CR, et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Respir Cell Mol Biol,2005; 33(2):145-152.
[84]邓为民,李长虹,廖联明,等.成体骨髓源多能间充质干细胞体内分化为皮肤干细胞和皮肤组织.细胞生物学杂志,2003；25(2)：98-104.
[85]李海红,付小兵,王君,等.间充质干细胞分化为表皮附属细胞的初步实验研究.中国修复重建外科杂志,2006；20(6)：675-678.
[86]刘德伍,李国辉,胡翔,等.骨髓间充质干细胞复合胶原构建组织程皮肤修复皮肤缺损.中国临床康复,2005；9(2)：90-91.
[87]Vojtassak J, Danisovic L, Kubos M, et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocdnol Lett,2006; 27(12):134-137.
[1]张进,徐志伟,杜少辉,等.“精”学说与干细胞辨识.中医药学刊,2004；22(7)：1198-1200.
[2]张进,徐志伟.补肾法诱导间充质干细胞向神经方向分化研究.现代医院,2004；4(9)：15-17.
[3]张进,徐志伟,陈群,等.干细胞与中医基础理论中的先天之精学说.中国临床康复,2006110(7)：189-192.
[4]张建新.经络是干细胞系——兼论物种的起源与干细胞系的进化.中国中医基础医学杂志,2001；7(4)：17-20.
[5]张建新.待验证的揭示人体干细胞分布与分类的中医经络学说.中国中医基础医学杂志,2004；10(6)：13.
[6]刘柏炎,蔡先先.试论中医学精气与干细胞生物学的关系.湖南中医学院学报,2003；23(6)：29-30.
[7]郑展,王菊勇.肿瘤干细胞研究进展与扶助肾中精气抗癌.国际中西医肿瘤研究论坛论文专辑,2008；218-226.
[8]张莽,赵如同,赵艳明.成体组织干细胞与“肾先天之精”的相关性研究概述.中医杂志增刊,2006；47：234-235.
[9]肖党生,俞玲娣,余国友,等.试探干细胞与五行相生的相关性.浙江中医杂志,2007；42(11)：669-671.
[10]李利清,张新光,虞坚尔.中医藏象精气与干细胞关系研究.环球中医药,2010；3(1)：39-41.
[11]李显澎,范海蛟,樊粤光,等.补肾法诱导骨髓间充质干细胞定向成骨分化的研究进展.中医药导报,2007：13(12)：81-84.
[12]李瀚旻.“肝肾同源于脑”与肝肾本质研究.中医杂志,2000,41(2)：69-71.
[13]杜少辉,陈东风,李伊为,等.龟板对脑缺血大鼠骨髓间充质干细胞移植后转分化为神经元的影响.中华医学杂志,2005；85(3)：205-207.
[14]李瀚曼.中医再生医学概论.中华中医药学刊,2008；26(11)：2309-2312.
[15]冼绍祥,杨忠奇,汪朝晖,等.黄芪甲苷体外诱导骨髓间充质干细胞分化为心肌样细胞的实验研究.广州中医药大学学报,2007；24(1)：37-40.
[16]杨忠奇,冼绍祥,李南夷,等.三七总苷对骨髓间充质干细胞分化为心肌样细胞的作用：中药新药与临床药理,2006；17(4)：139-142.
[17]汪朝晖,冼绍祥.杨忠奇,等.人参总甙诱导骨髓间充质干细胞分化为心肌样细胞的实验研究.广州中医药大学学报,2006；23(2)：100-103.
[18]陈嘉,孙京臣,邹移海,等.丹酚酸B诱导骨髓间充质干细胞向心肌样细胞分化.第四军医大学学报,2007；28(23)：2152-2155.
[19]孙连胜,徐秀梅,郭茂娟,等.丹酚酸B体外干预骨髓间充质干细胞分化过程中cTnT的表达.天津中医药,2007；24(4)：318-320.
[20]范英昌,华声瑜,姚雅娟.丹酚酸B诱导体外培养大鼠骨髓基质细胞向心肌细胞分化的研究.天津中医学院学报,2005；24(1)：10-12.
[21]王金津,钱夕元,李雪,等.双龙方有效成分诱导干细胞分化过程中差异表达基因筛选和聚类分析.世界科学技术一中医药现代化,2007；9(3)：39-42.
[22]杨庆有,冼绍祥,孙慧茹,等.黄芪含药血清诱导骨髓间充质干细胞分化为心肌样细胞的实验研究.辽宁中医杂志,2008；35(6)：832-834.
[23]叶能胜,赵艳峰,张荣利,等.双龙方干预骨髓间质充质干细胞分化过程的蛋白表达.中成药,2007；29(1)：24-29.
[24]宋清,张晓文,户新政,等.参三七皂苷Rg预适应对5-氮胞苷诱导大鼠骨髓间充质干细胞向心肌细胞转化的干预.中国组织工程研究与临床康复,2007；11(24)：4693-4697.
[25]王和鸣,王力,李楠,等.巴戟天对骨髓基质细胞向成骨细胞分化影响的实验研究.福建中医学院学报,2004；14(3)：16-20.
[26]陈伟才,罗军.杜仲叶提取物诱导羊骨髓间充质干细胞成骨及抑制其成脂肪分化.中国组织工程研究与临床康复,2009；13(10)：1960-1964.
[27]刘海江,王小平,林娟,等.淫羊藿苷和黄芪苷I对骨髓基质细胞增殖及成骨能力的影响[J].中药材,2006(10)：1063-1065.
[28]郑良朴,李楠,王和鸣.补骨合剂对体外培养骨髓基质细胞分化影响的观察.福建中医学院学报,2003；13(6)：33-35.
[29]马慧萍,贾正平,张汝学,等.淫羊藿总黄酮含药血清促进骨髓间充质干细胞增殖与成骨性分化.中国骨质疏松杂志,2004；10(4)：420.
[30]程志安,宋少云,吴燕峰,等.健骨二仙丸介导间充质干细胞的成骨细胞定向分化诱导及其成骨活性.中国中医骨伤科杂志,2005；13(1)：8-11.
[31]曾建春,樊粤光,刘建仁,等.杜仲含药血清诱导骨髓间充质干细胞定向分化的实验研究.时珍国医国药,2009；20(9)：2316-2318.
[32]丘友如,陈玉兴.温阳通络胶囊含药血清对去卵巢大鼠骨髓间充质干细胞成骨活性的影响.实用医学杂志,2006；22(11)：1241-1242.
[33]范红旗,孙辉生,刘振旗,等.复方接骨中药对骨髓间充质干细胞体外增殖及向成骨细胞分化的影响.中国组织工程研究与临床康复,2007；11(10)：1818-1825.
[34]项鹏,夏文杰,张丽蓉,等.成人骨髓间质干细胞定向诱导为神经元样细胞的研究.中国病理生理杂志,2001；17(5)：385-387.
[35]肖庆忠,温冠媚,李浩威,等.麝香组分诱导成年大鼠骨髓间质干细胞体外定向分化为神经元样细胞的能力.中山医科大学学报,2002；23(6)：405-409.
[36]撒亚莲,李海标.三七总皂甙诱导骨髓间质干细胞分化为神经元样细胞.中山医科大学学报,2002；23(6)：409-410,437.
[37]郑国庆,王小同,邬伟,等.人参总皂苷体外诱导大鼠骨髓间充质干细胞分化为神经元样细胞.中华中医药学刊,2008；26(6)：1257-1259.
[38]蔡光先,林琳,刘柏炎,等.地黄多糖诱导骨髓间充质干细胞分化为神经样细胞的效应.中国临床康复,2005；9(17)：46-47.
[39]夏文杰,陈振光,张丽蓉,等.隐丹参酮诱导骨髓间质干细胞分化为神经元样细胞的实验研究.中国中西医结合杂志,2002；22(12)：921-924.
[40]夏文杰,项鹏,张丽蓉,等.丹参酮ⅡA定向诱导骨髓间质干细胞分化为神经元样细胞的研究.中国病理生理杂志,2003：19(7)：865-869.
[41]撒亚莲,李海标.川芎嗪诱导大鼠骨髓间质干细胞分化为神经元样细胞的研究.解剖学报, 2003；34(5)：514-517.
[42]向平,李海标.黄连素诱导大鼠骨髓间质干细胞分化为神经元样细胞.中国病理生理杂志,2004；20(1)：51-53.
[43]贾延劫,杨于嘉.宋元宗.黄芩甙体外诱导大鼠骨髓基质细胞成为神经细胞.中国病理生理杂志,2002：18(3)：247-249.
[44]余勤,连俊兰,郭莹.丹参注射液诱导骨髓间质干细胞分化为神经元样细胞的实验研究.中国中西医结合急救杂志,2006；13(4)：210-213.
[45]常宏,蒋绍艳,史玉朋,等.丹参注射液诱导大鼠骨髓间充质干细胞分化为神经元样细胞的研究.中国药房,2008；19(30)：2323-2325.
[46]刘金保,董晓先,董燕湘,等.多种中药成分诱导大鼠骨髓间质干细胞转变为神经元样细胞.中国药物与临床,2003；3(3)：234-236.
[47]王勇,陆长青,王凡.黄芪诱导大鼠骨髓间充质干细胞分化为神经样细胞的研究.四川解剖学杂志,2006；14(1)：5-8.
[48]董立华,王勇,陆长青.黄芪诱导大鼠骨髓间充质干细胞分化为神经样细胞的研究.四川大学学报(医学版),2007：38(3)：417-420.
[49]邝学媚,廖欣,杜少辉,等.三甲复脉汤含药血清体外诱导成年大鼠骨髓间充质干细胞分化为神经元.中国临床康复,2005；9(30)：53-55.
[50]黄洁,杜少辉,张宜,等.牛珀至宝微丸诱导成年大鼠骨髓间充质干细胞分化为神经元的研究.江西中医药,2003；34(10)：40-41.
[51]杜少辉,陈东风,李伊为,等.龟板对脑缺血大鼠骨髓间充质干细胞移植后转分化为神经元的影响.中华医学杂志,2005：85(3)：205-207.
[52]姚晓黎,张成,卢锡林,等.参芪扶正注射液诱导成人问质干细胞治疗脑梗塞的实验研究.中国中西医结合杂志,2005；25(7)：629-632.
[53]汤治黎,章汉平,李源,等.丹参注射液诱导大鼠骨髓间充质干细胞分化为成软骨细胞的研究.湖北中医杂志,2008：30(6)：11-12.
[54]肖鲁伟,武中庆,季卫锋,等.右归饮诱导胎兔骨髓基质细胞向软骨细胞分化的实验研究.中国中医药科技,2005；12(3)：154-155,175.
[55]李楠,王和鸣,李文顺,等.龟鹿二仙胶汤含药血清对兔体外BMSCs向软骨细胞分化的干预作用.上海中医药大学学报,2007；21(6)：58-61.
[56]吴追乐,刘献祥,李西海,等.透骨消痛颗粒诱导骨髓间充质干细胞向软骨细胞的分化.中国组织工程研究与临床康复,2009；13(33)：6456-6460.
[57]王大伟,潘华,李红波,等.三七总皂苷对酒精诱导骨髓基质干细胞分化影响的实验研究.中国组织工程研究与临床康复,2008；12(8)：1410-1413.
[58]闫金松,魏志杰,王冰,等.中药祛脂素对再生障碍性贫血患者骨髓间充质干细胞脂肪分化的干预.中国组织工程研究与临床康复,2008；12(25)：4873-4876.
[59]徐无忌,庄洪.骨康含药血清对大鼠骨髓间充质干细胞成脂分化的影响.中国组织工程研究与临床康复,2008；12(43)：8434-8438.
[1]Matsubara T, Tsutsumi S, Pan H, et al. A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix. Bioehem BiophysRes Commun, 2004; 313(3):503-508.
[2]Hashimoto J, Kariya Y, Miyazaki K. Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332). Stem Cells, 2006; 24(11):2346-2354.
[3]Chen XD, Dusevich V, Feng JQ, et al. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res,2007; 22(12):1943-1956.
[4]万千雪.胞外基质、细胞因子及机械刺激对大鼠骨髓间充质干细胞增殖的调节作用[硕士学位论文].重庆：重庆大学,2008.
[5]周炳荣,华子春,胡勤刚,等.P-6对人骨髓间充质干细胞黏附和增殖特性的影响.口腔医学研究,2004；20(1)：19-21.
[6]Jager M, Feser T, Denck H, et al. Proliferation and osteogenic differentiation of mesenchymal stem cells cultured onto three different polymers in vitro. Ann Biomed Eng, 2005; 33(10):1319-1332.
[7]Larsen M, Artym VV, Green JA, et al. The matrix reorganized:extracellular matrix remodeling and integrin signaling. Curt Opin Cell Biol,2006; 18(5):463-471.
[8]Kotev Emeth S, Pitaru S, Pri Chen S, et al. Establishment of a rat long-term culture expressing the osteogenic phenotype:dependence on dexamethasone and FGF-2. Connect Tissue Res,2002; 43(4):606-612.
[9]Solchaga LA, Penick K, Porter JD, et al. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol, 2005; 203(2):398-409.
[10]Scutt A, Bertram P. Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif Tissue Int,1999; 64(1):69-77.
[11]Hankemeier S, Keus M, Zeichen J, et al. Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2:potential implications for tissue engineering of tendons and ligaments. Tissue Eng,2005; 11(1-2):41-49.
[12]Locklin RM, wiliamson MC, Beresford JN, et al. In vitro effects of growth factors and dexamethasone on rat marrow stroml cells. Clin Orthop,1995; 313(1):27-35.
[13]俞猛,徐万鹏,于方,等.TGF-β1和bFGF对骨髓基质干细胞增殖、分化的影响.中国骨肿瘤骨病,2006；5(6)：321-325.
[14]Locklin RM, Oreffo RO, Triffitt JT. Effects of TGF beta and bFGF on the differentiation of human bone marrow stromal fibroblasts Cell. Biol Int,1999; 23(3):185-194.
[15]Warzecha J, Gottig S, Brflning C, et al. Sonic hedgehog protein promotes proliferation and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro. J Orthop Sci,2006; 11(5):491-496.
[16]De Boer J, Wang HJ, Van Blitterswijk C. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng,2004; 10(3-4):393-401.
[17]刘岐焕,程范军,陈龙,等.粒细胞集落刺激因子对小鼠骨髓间充质干细胞的作用.武汉大学学报(医学版),2007；28(3)：336-340.
[18]Mayr-Wohlfart U, Kessler S, Knochel W, et al. BMP-4 of Xenopus laevis stimulates differentiation of human primary osteoblast-like cells. J Bone Joint Surg Br,2001; 83(5): 777-784.
[19]Tamama K, Fan VH, Grifith LG, et al. Epidermal growth factor as a candidate for exvivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells,2006; 24(3):686-695.
[20]张海红,侯相麟,王小蕊.促红细胞生成素对人骨髓间充质干细胞增殖和细胞周期的影响.中国组织工程研究与临床康复,2008；12(29)：5671-5674.
[21]柴海霞,程范军,高清平,等.促血小板生成素对小鼠骨髓干细胞增殖的影响.中华器官移植杂志,2008；29(2)：86-89.
[22]张卫兵,洪光祥,康皓.富血小板血浆对兔骨髓间充质干细胞增殖的作用.中国组织工程研究与临床康复,2008；12(34)：6639-6642.
[23]Muller I, Kordowich S, Holzwarth C, et al. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy,2006; 8(5):437-444.
[24]Doucet C, Ernou I, Zhang Y, et al. Platelet lysates promote mesenchymal stem cell expansion:a safety substitute for animal serum in cell-based therapy applications. J Cell Physiok,2005; 205(2):228-236.
[25]Gruber R, Karreth F, Kandler B, et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets,2004; 15(1):29-35.
[26]Krampera M, Pasini A, Rigo A, et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells:inducing cell expansion and reversibly preventing multilineage differentiation. Blood,2005; 106(1):59-66.
[27]Carcamo-Orive I, Tejados N, Delgado J, et al. ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential. Exp Cell Res,2008; 314(8):1777-1788.
[28]Levy 0, Dvir T, TsurGang 0, et al. Signal transducer and activator of transcription 3-A key molecular switch for human mesenchymal stem cell proliferation. Int J Biochem Cell Biol,2008; 40(11):2606-2618.
[29]Bocker W, Docheva D, Prall WC, et al. IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells. J Mol Med,2008; 86(10):1183-1192.
[30]De Boer J, Siddappa R, Gaspar C, et al. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone,2004; 34(5):818-826.
[31]Colvin GA, Lambert JF, Carlson JE, et al. Rhythmicity of engraftment and altered cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static cultures. In Vitro Cel Dev Biol Anim,2002; 38(6):343-351.
[32]Chen XD, Dusevich V, Feng JQ, et al. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res,2007; 22(12):1943-1956.
[33]Colvin GA, Lambert JF, Carlson JE, et al. Rhythmicity of engraftment and altered cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static cultures. In Vitro CelDev Biol Anim,2002; 38(6):343-351.
[34]Song G, Ju Y, Soyama H, et al. Regulation of cyclic longitudinal mechanical stretch on proliferation of human bone marrow mesenchymal stem cells. Mol Cell Biomech,2007; 4(4):201-210.
[35]黎润光,邵景范,魏明发,等.牵张应力对人骨髓间充质干细胞增殖及细胞周期的影响.中国组织工程研究与临床康复,2007；11(7)：1247-1251.
[36]李正章,程应樟,吴险峰,等.周期性压力培养对免骨髓问充质干细胞增殖的影响.中国组织工程研究与临床康复,2009；13(19)：3628-3632.
[37]徐巧玲,罗二平,路丽华.恒磁场对大鼠骨髓间充质干细胞增殖的影响.中国医学物理学杂志,2009；26(1)：999-1002.
[38]方真华,吴华,马伟明,等.50Hz电磁场对小鼠骨髓间充质干细胞增殖的影响.中华物理医学与康复杂志,2004；26(1)：1-4.
[39]Liedert A, Kaspar D, Blakytny R, et al. Signal transduction pathways involved in mechanotransduction in bone cells. Bioehem Biophys Res Commun,2006; 349(1):1-5.
[40]Ko KS, McCulloch CA. Intercellular mechanotransduction:cellular circuits that coordinate tissue responses to mechanical loading. Bioehem Biophys ResBiophys Res Commun, 2001; 285(5):1077-1083.
[41]Li YJ, Batra NN, You L, et al. Oscillatory fluid flow affects human marrow stromal cell proliferation and differentiation. J Orthop Res,2004; 22(6):1283-1289.
[42]戚孟春,胡静,邹淑娟,等.机械力学对体外骨髓间充质干细胞的影响.华西口腔医学杂志,2005；23(2)：110-113.
[43]Riddle RC, Taylor AF, Genetos DC, et al. MAP kinase and calcium signaling mediate fluid flow-induced human mesenchymal stem cell proliferation. Am J Physiol Cell Physiol, 2006; 290(3):C776-C784.
[44]Simmons CA, MatlisS, Thornton AJ, et al. Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech,2003; 36(8):1087-1096.
[45]赵东明,吴华,黄珊珊,等.电磁场激活细胞外信号调节激酶通路在骨髓间充质干细胞增殖与分化成骨中的作用.中华物理医学与康复杂志,2008；30(8)：515-518.
[46]郭少三,黄畅,韩大良,等.人参茎叶皂苷对体外条件下小鼠骨髓间充质干细胞和粒一巨噬系祖细胞增殖的影响.中医药导报,2007；13(6)：6-9,14.
[47]韩大良,黄畅,郭少三,等.人参皂苷Rbl对体外条件下小鼠骨髓间充质干细胞和粒一巨噬系祖细胞增殖的影响.中华中医药学刊,2008；26(6)：1192-1193.
[48]王力,吴鑫,卢新政,等.人参皂苷Rgl对培养大鼠骨髓间充质干细胞增殖影响的机制研究.中国药理学通报,2007；23(11)：1480-1484.
[49]吴涛,徐俊昌,南开辉,等.淫羊藿苷促进羊骨髓间充质干细胞的增殖和成骨分化.中国组织工程研究与临床康复,2009；13(19)：3725-3729.
[50]李志泉,冼绍祥,汪朝晖,等.三七总皂苷对骨髓间充质干细胞增殖和向心肌样细胞分化的影响.广州中医药大学学报,2007；24(6)：470-474.
[51]许春娇,翦新春,郭峰华,等.黄芪多糖对犬骨髓基质干细胞增殖及超微结构的影响.华西口腔医学杂志,2007；25(5)：432-436.
[52]修忠标,林建华.鹿茸多肽对人骨髓间充质干细胞体外增殖的影响.福建中医学院学报,2005；15(1)：34-37.
[53]李熙灿,周健洪,黎晖,等.荜提取物对大鼠骨髓间充质干细胞的增殖作用及与化学官能团的关系.中药材,2005；28(7)：570-573.
[54]马慧萍,贾正平,张汝学,等.淫羊藿总黄酮含药血清促进骨锈间充质干细胞增殖与成骨性分化.中国骨质疏松杂志,2004；10(4)：420-422,428.
[55]董群伟,孙奋勇,王华,等.牛膝含药血清对体外培养人间充质干细胞增殖与分化的影响.广东药学院学报,2006；22(2)：185-187.
[56]陈薇,曾和平,王春艳,等.中药龟板提取物化学成分及其调控鼠骨髓间充质干细胞增殖活性的实验研究.化学学报,2007；65(3)：265-270.
[57]张越华,曾和平,陈东风,等.龟板脂肪酸调控鼠骨髓间质干细胞增殖作用.生物工程学报,2007；23(6)：304-309.
[58]黎晖,李春,陈东风,等.龟板含药血清促进骨髓间充质干细胞骨形态发生蛋白4的表达.解剖学报,2007；38(3)：304-309.
[59]郑庆元,余伟吉,杜少辉,等.龟板含药血清对骨髓间充质干细胞增殖细胞核抗原表达的影响.中华中医药学刊,2008；26(2)：268-270.
[60]陈薇,曾和平,王婷婷.中药四物汤提取物调控鼠骨髓间充质干细胞增殖活性的化学成分分析.分析化学研究报告,2008；36(4)：459-466.
[61]周晓东,宋宇轩,张丽君,等.桂附地黄丸对骨髓基质干细胞增殖能力的影响.家畜生态学报,2005；26(2)：56-58.
[62]张文海,李秀兰,张杨,等.中药生肌液对兔骨髓间充质干细胞增殖活性的影响.中国中西医结合外科杂志,2007；13(2)：146-149.
[63]曾意荣,樊粤光,刘红,等.补肾活血中药对大鼠骨髓间充质干细胞体外增殖的影响.中药新药与临床药理,2007；18(2)：93-96.
[64]范红旗,孙辉生,刘振旗,等.复方接骨中药对骨髓间充质干细胞体外增殖及向成骨细胞分化的影响.中国组织工程研究与临床康复,2007；11(10)：1818-1821,182.
[65]陈凯佳,刘小斌,邱仕君,等．强肌健力口服液含药血清对大鼠骨髓间充质干细胞体外增殖的影响.中国中医药信息杂志,2008；15(2)：23-25.
[66]王明宁,林洪,胡琳,等.香丹注射液对大鼠骨髓间充质干细胞的增殖作用.华西药学杂志,2007：22(3)：304-305.
[67]王明宁,胡琳,胡火珍,等.四种中药注射液对大鼠骨髓间充质干细胞增殖作用的影响.四川动物,2008；27(6)：1130-1132.
[68]王明宁,胡琳,马祁生,等.刺五加注射液对骨髓间充质干细胞增殖的影响.青海医学院学报,2008；29(2)：116-118.
[69]王明宁,胡琳,侯成荣,等.刺五加、黄芪、参麦、生脉注射液对大鼠骨髓间充质干细胞增殖的影响比较.山东医药,2009；49(6)：38-39.
[70]王明宁,胡琳.低氧环境中几种中药注射液对大鼠骨髓间充质干细胞增殖的影响.高原医学杂志,2009；19(2)：7-9.
[1]Lisignoli G, Remiddi G, Cattini L. An elevated number of differentiated osteoblast colonies can be obtained from rat bone marrow stromal cells using a gradient isolation procedure. Connect Tissue Res,2001; 42(1):49-57.
[2]项平,黄锦桃,撒亚莲,等.大鼠骨髓间充质干细胞的培养及鉴定.蚌埠医学院学报,2005；30(1)：1-4.
[3]Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation,1968; 6(2):230-247.
[4]Colter DC, Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA, 2000; 97(7):3213-3218.
[1]汪鸿宇,俞仲毅,李仪奎,等.血清药理实验中不同动物种属血清对脾脏淋巴细胞的影响.中国中医药科技,2001：8(3)：185.
[2]刘成海,刘成,刘平.抗肝纤维化有效中药复方血清药理学方法探讨.中国实验方剂学杂志,1998-4(2)：16-19.
[3]曹俊,张红梅,王旋.中药血清药理学研究概况.中国中医药信息杂志,2002；9(1)：80-92.
[4]王力倩,李仪奎,符胜光,等.血清药理学方法研究探讨.中药药理与临床,1997；13(3)：29-31.
[5]李仪奎.中药血清药理学试验方法的若干问题.中药新药与临床药理,1999；10(2)：95-97.
[6]王宁生.关于血清药理学的若干思考.中国新药与临床药理,1999；10(5)：263-266.
[7]陈奇.中药药理研究方法学.北京：人比卫生出版社,第一版,1993：1103.
[8]王吕俊.扶正抗癌方药物血清对人肝癌细胞增殖的影响.中西医结合肝病杂志,1997；7(4)：214-216.
[9]刘成海.扶正化瘀复方药物血清对大鼠肝贮脂细胞增殖及胶原合成的影响.中国实验方剂学 杂志,1996；2(2)：16-19.
[10]李仪奎,吴健宇.血清药理实验中采血时间的通法方案.中国药理学通报,1999；15(6)：569-570.
[11]蒙一纯,丁霞,贲长恩.中药血清药理学应用研究展望.北京中医药大学学报,1999；22(4)：42-44.
[12]崔晓兰,贺玉琢,高英杰,等.中药复方血清药理方法学探讨.中国实验方剂学杂志,1999；5(3)：36-37.
[13]徐海波,吴清和.中药血清药理学实验方法的探讨.中国中医药科技,2000；7(1)：43-44.
[14]周明眉,杨奎,姜远平,等.中药血清药理学的方法学研究——反应体系中含药血清加入量的研究.中药药理与临床,1998；14(6)：43-44.
[15]吴健宇,李仪奎,符胜光,等.补阳还五汤保护自由基损伤血管内皮细胞的血清药理实验方法的建立.中药药理与临床,1999；15(1)：45-46.
[16]管淑玉,苏薇薇.何首乌的化学成分和药理作用研究进展.中南药学,200816(4)：454-455.
[17]陈计,夏炎兴,杨秋美,等.何首乌吸收成分对大鼠二倍体细胞生长和传代的影响.上海中医药杂志,1995；8：41-42.
[18]金哲雄,金政.何首乌对缺氧培养心肌细胞保护作用的实验研究.时珍国医国药,2006；17(8)：1454-1456.
[19]邓响潮,黄俊柅,练志文,等.何首乌不同提取物对小鼠脾淋巴细胞的增殖作用.中国现代药物应用,200812(8)：1-3.
[20]熊平源,胡艺兰,郭凯文,等.何首乌对小鼠腹腔巨噬细胞功能的影响.数理医药学杂志,2007；20(3)：370-371.
[21]胡存华,赵立波,王晓敏,等.THSG增强正常血管内皮细胞抗氧化作用研究.医药导报,2007：26(2)：138-139.
[22]刘莉萍,杨耀防,何明,等.THSG对人脐静脉血管内皮细胞缺氧复氧损伤的影响.中国组织工程研究与临床康复,2009；7(13)：1320-1323.
[23]王文权,张韶辉,赵立波,等.THSG抑制人乳腺癌MCF-7细胞增殖及对PDK/Akt信号通路的影响.肿瘤,2009；29(1)：26-30.
[24]Kinnaird T, Stabile E, Burnett MS, et al. Marrow derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res,2004; 94(5):678-685.
[25]Neuhuber B, Timothy Himes B, Shumsky JS, et al. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res,2005; 1035(1):73-85.
[26]Sze SK, de Kleijn DP, Lai RC, et al. Elucidating the secretion proteome of human embryonic stem cellderived mesenchymal stem cells.Mol Cell Proteomics,2007; 6(10): 1680-1689.
[27]Lee RH, Kim B, Choi I, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem,2004; 14(4-6): 311-324.
[28]Takahashi M, Li TS, Suzuki R, et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol,2006; 291(2):H886-H893.
[29]Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation2independentmechanisms. Am J Physiol Renal Physiol,2005; 289(1):F31-F42.
[30]Xu M, Uemura R, Dai Y, et al. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol,2007; 42(1):441-448.
[31]Zhang M, Mal N, Kiedrowski M, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J,2007; 21 (12): 3197-3207.
[32]Martin FH, Suggs SV, Langley KE, et al. Primary structure and functional expression of rat and human stem cell factor DNA. Cell,1990; 63(1):203-211.
[33]Anderson DM, Lyman SD, Daird A, et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell,1990; 63(1):235-243.
[34]Inenberger MI, Jacobsen FW, Bennett LG, et al. Stem cell factor and hematopoiesis.Blood,1997; 90(4):1345-1364.
[35]潘明,张鸣.干细胞因子研究概况.国外医学临床生物化学与检验学分册,2005；26(9)：597-599.
[36]Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor and mast cells what each is teaching us about the others. AmJ Pathol,1993; 142(4):965-947.
[37]Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infracted heart, improving function and survival. Proc Natl Acad Sci,2001; 98(18): 10344-10349.
[38]Kocher AA, Schuster MD, SzbolcsML, et al. Neovascularization of ischemic myocardium by human bone marrow derived angioblasts prevents cardio myocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med,2001; 7 (4):430-436.
[39]Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature,2001; 410(6829):701-705.
[40]Takano H, Ohtsuka M, Akazawa H, et al. Pleiotropic effects of cytokines on acute myocardial infarction:G-CSF as a novel therapy for acute myocardial infarction. Current pharmaceutical design,2003; 9(14):1121-1127.
[41]Dormady SP, Bashayan 0, Dougherty R, et al. Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. Journal of hematotherapy &stem cell research,2001; 10(1):125-140.
[42]Woldbaek PR, Hoen IB, Christensen G, et al. Gene expression of colony stimulating factors and stem cell factor after myocardial infarction in the mouse. Acta physiologica Scandinavica,2002; 175(3):173-181.
[1]国家药典委员会.中国药典.北京：化学工业出版社,2005,第1版：215.
[2]龚莉,向大雄,隋艳华.黄精醇提物对心肌缺血大鼠心脏组织中AST、CK、LDH等活性及心肌 坏死病理变化的影响.中医药导报,2007；13(6)：99-101.
[3]胡国柱,聂荣庆,肖移生.黄精多糖对新生大鼠大脑皮层神经细胞缺氧性凋亡的影响.中药药理与临床,2005；21(4)：37-39.
[4]文珠,肖移生,唐宁.黄精多糖对神经细胞的毒性及抗缺氧性坏死和凋亡作用研究.中药药理与临床,2006；22(2)：29-31.
[5]赵小贞,王玮,康仲涵.黄精口服液对血管性痴呆大鼠行为和海马星形胶质细胞的影响.中国行为医学科学,2008；17(10)：875-877.
[6]Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells and stromal cell. J Cell Physiol, 1998; 176(1):57-66.
[7]Dormady SP, Bashayan 0, Dougherty R, et al. Immortalized multipotential mesenchymal stem cells and the hematopoietic microenvironment. J Hematother Stem Cell Res,2001; 10(1):125-140.
[8]Fruehauf S, Veldwi jk MR, Kramer A, et al. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cell from steady-state bone marrow and peripheral blood mobilized following GCSF-suprcrted chemotherapy. Stem Cells,1998; 16(4):271-279.
[9]Watari K, Asano S, Shirafuji N, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoloassay. Blood,1989; 73(1):117-20.
[10]李洪,许志恩,李维,等.粒细胞集落刺激因子对大鼠骨髓间充质干细胞增殖的影响.中国脑血管病杂志,2008；5(10)：461-465.
[1]国家药典委员会.中国药典.北京：化学工业出版社,2005,第1版：55-56.
[2]陈彩英,詹若挺,陈蔚文.巴戟天的药理研究进展.中药新药与临床药理,2009；20(3)：291-293
[3]林励、徐鸿华.不同年龄巴戟天微量元素、氨基酸及糖含量测定.广州中医学院学报,1992；9(3)：160-163.
[4]李楠,王和鸣,林旭.巴戟天对成骨细胞生物学特性影响的实验研究.中国医药学报,2004：19(12)：726-728.
[5]李楠,王和鸣,郭素华,等.巴戟大多糖及其水提取物对体外培养成骨细胞活性的影响.中国组织工程研究与临床康复,2007；7(2)：4570-4572.
[6]王和鸣,王力,李楠.巴戟天对骨髓基质细胞向成骨细胞分化过程Cbf α1表达的影响.中国中医骨伤科杂志,2004；12(6)：22-26,29.
[7]李楠,王和鸣,郭素华,等.巴戟天多糖对体外培养成骨细胞核心结合因a ImRNA表达的影响.中华中医药杂志,2007；22(8)：517-519.
[8]李楠,王和鸣,郭素华,等.巴戟天多糖含药血清对体外培养成骨细胞凋亡的保护作用观察.中国骨伤,2008：21(1)：39-41.
[9]张贺鸣,韩联合,冯国清.巴戟天对培养乳鼠心肌细胞缺氧复氧损伤的防护作用.河南中医学院学报,2005；20(3)：20-21.
[10]韩联合,冯国清,张贺鸣.巴戟天正丁醇提取物对乳鼠心肌细胞缺氧／复氧损伤后炎性细胞 因子的影响.中国医院药学杂志,2008；28(17)：1450-1453.
[11]潘新宇,牛岭.巴戟天对过度训练大鼠心肌细胞凋亡的影响.中国临床康复,2006；10(3)：102-103.
[12]黄涛,李楠,王和鸣.巴戟天多糖对体外培养兔软骨细胞增殖的影响.北京体育大学学报,2007；30(9)：1216-1218.
[13]王奎鹏,冯国清,胡香杰.巴戟天寡糖对成肌细胞增殖及分化的影响.中国药理通讯,2009；26(2)：43.
[14]赵辉,梁惠宾.巴戟天对人体及小鼠淋巴细胞增殖的影响.中医杂志,2002；43(1)：57-58.
[15]尹永英.巴戟天对脐血CD34细胞体外扩增的影响.现代预防医学,2006；33(8)：1351.
[16]潘文灏,许志超,赵余庆.菟丝子的生物活性与临床应用研究进展.亚太传统医药,2008；4(4)：47-51.
[17]谢雁鸣,秦林林,于向东,等.骨碎补、淫羊藿、菟丝子总黄酮对成骨细胞体外培养影响的比较研究.中华中医药杂志,2005；12(7)：22-23.
[18]王晓敏,王建红,伍庆华,等.菟丝子黄酮对去势雌性大鼠血清雌激素水平和血管平滑肌细胞的影响.天津医药,2005；33(10)：650-651.
[19]王晟,秦达念.菟丝子总黄酮对大鼠睾丸曲细精管无血清培养所致细胞凋亡的保护作用.中国药理学通报,2006；22(8)：984-987.
[20]真国辉,姜波,包永明,等.菟丝子黄酮类组分对H202损伤PCI2细胞的保护作用.中药材,2006；29(10)：1051-1055.
[21]刘悦,季晖,蔡曼玲.蛇床子、菟丝子及其复方对体外培养成骨细胞和破骨细胞的影响及血清药理学研究.中国药理通讯,2004；21(3)：14.
[22]沈骅睿,吕文科,胡晓梅.菟丝子定向诱导成骨细胞向神经元细胞转化的研究.中华实用中西医,2005；18(21)：1549-1551.
[23]李志刚,姜波,包永明,等.菟丝子提取物对MPP十诱导的PCI2细胞凋亡的保护作用.中成药,2006；28(2)：219-222.
[24]王利华,卜鹏程,包永明.菟丝子提取物对活性氧引起已分化的PCI2细胞损伤的保护作用.细胞生物学,2005；27：69-72.
[25]刘建辉,姜渡,包永明,等.菟丝子提取物在PCI2细胞株中的神经营养样作用.生物化学与生物物理进展,2003；30(2)：226-227.
[26]Prevost JM, Farrell PJ, Iatrou K, et al. Determinants of the functional interaction between the soluble GM-CSF receptor and the GM-CSF receptor beta-subunit. Cytokine, 2000; 12(3):187-197.
[27]Hartung T. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol,1998; 5(3):221-225.
[28]Kimber SJ. Leukaemia inhibitory factor in implantation and uterine biology. Reproduction,2005; 130(2):131-145.
[29]Ni H, Ding NZ, Harper MJ, et al. Expression of leukemia inhibitory factor receptor and gp130 in mouse uterus during early pregnancy. Mol Reprod Dev,2002; 63(2):143-150.
[30]Zvonic S, Baugh JE. Arbout-Rcily P, et al. Cross-talk among gp130 cytom in adipoeytes. Biochem Mol Biol,2005; 280(40):33856-33863.
[31]Liu T, Gao Y, Sakamoto K, et al. BMP-2 promotes differentiation of osteoblasts chondroblasts in Runx2-deficient cell lines. J Cell Physiol,2007; 211(3):728-735.
[32]Freyria AM, Courtes S, Mallein-Gerin F. Differentiation of aduh human mesenchymal stem cells:chondrogenic effect of BMP-2. PatholBiol,2008; 56:326-333.
[33]Mayr-Wohlfart U, Kessler S, Knochel W, et al. BMP-4 of Xenopus laevis stimulates differentiation of human primary osteoblast-like cells. J Bone Joint Surg Br,2001; 83(5): 777-784.
[1]王新生,崔慧先,马海东,等.黄芪诱导骨髓间充质干细胞向神经干细胞分化.解剖学杂志,2007；30(5)：534-537.
[2]王勇,陆长青,王凡.黄芪诱导大鼠骨髓间充质干细胞分化为神经样细胞的研究.四川解剖学杂志,2006；14(1)：5-8.
[3]邹萍,胡翔,刘德伍.黄芪诱导人骨髓间充质干细胞向表皮样细胞的分化.中国组织工程研究与临床康复,2009；13(36)：7099-7102.
[4]陈阿琴,杨志刚,俞颂东,等.黄芪多糖药理作用研究进展.中国兽药杂志,2005；35(9)：33.
[5]刘毅,王文健,陈伟华,等.黄芪多糖对3T3-L1前脂肪细胞增殖和分化的影响.中西医结合学报,2007；5(4)：421-426.
[6]李萍,何秀娟,张颖一,等.黄芪多糖对细胞增殖及血管内皮细胞与白细胞粘附作用的影响.中国病理生理杂志,2004,20(9)：1677-168.
[7]张霄翔,杨雁,陈敏珠.黄芪多糖对HSC-T6细胞增殖及胶原产生的影响.中国临床药理学与治疗学,2003；8(6)：645-647.
[8]房信胜,穆象山,周红英,等.黄芪皂苷和黄芪多糖对大鼠肾脏系膜细胞增殖的影响.时珍国医国药,2008；19(6)：1448-1449.
[9]许春娇,翦新春,郭峰华,等.黄芪多糖对犬骨髓基质干细胞增殖及超微结构的影响.西口腔医学杂志,2007；25(5)：432-436.
[1]朱也君.加味左归丸治疗卵巢早衰继发性闭经30例.辽宁中医杂志,2008；35(3)：407-408.
[2]于淑云,刘玉蕾.加昧左归丸治疗更年期综合征160例.陕西中医,2007：28(9)：1178-1179.
[3]李素琴,张宏亮.左归丸加减治疗绝经前后诸症54例.四川中医,2005；23(6)：75.
[4]张君满.左归丸加减在妇科疾病中的应用.四川中医,2007；25(5)：85.
[5]朱玲,罗颂平,许丽绵.左归丸对免疫性卵巢早衰小鼠卵巢Fas、Fas-L表达的影响.江两中医学院学报,2008；20(1)：52-55.
[6]高唱,王景周.左归丸对体外培养新生大鼠海马神经干细胞增殖分化的影响.中国医药学报.2004；19(11)：691-693.
[7]李瀚曼,高翔,晏雪生.左归丸促进骨髓形成肝细胞的研究.世界华人消化杂志,2005；13(24)： 2818-2822.
[8]李瀚曼,张六通,邱幸凡,等.左归丸改善MSG-肝再生-大鼠肝肾精血亏虚证的作用机制研究.湖北中医学院学报,2001；3(4)：30-33.
[9]李瀚曼,晏雪生,罗建君,等.左归丸药物血清对骨髓间质细胞转化为肝细胞的作用.中国组织工程研究与临床康复,2007；28(11)：5465-5468.
[10]鞠大宏,赵宏艳,刘梅洁,等.左归丸含药血清对成骨细胞IL-1、IL-6和COX-2表达的影响.中国实验动物学报,2006；14(2)：96-99.
[11]赵宏艳,鞠大宏,刘梅洁.左归丸含药血清对破骨细胞骨吸收功能的影响以及成骨细胞对其的介导作用.中国中医基础医学杂志,2006；12(9)：662-664.
[12]Mets T, Verdonk G. In vitro aging of human bone marrow-derived stromal cells. Mech Ageing Dev,1981; 16(1):81-89.
[13]Dormady SP, Bashayan 0, Dougherty R, et al. Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res,2001; 10(1): 125-140.
[14]Vlase T, Vlase Gabriela, Doea N. Kineties of thermal decomposition of alkaline phosphates. Journal ofThermal Analysis&Calorimetry,2005; 80(1):207-210.
[15]Pittenger MF, Mackay AM, Beck SC, et al. Muitilineage potential of adult human mesenchymal stem cells. Science,1999; 284(5411):143-147.
[16]李冬菊,葛冬霞,吴文超,等.去卵巢骨质疏松大鼠骨髓间充质干细胞成骨分化能力研究.四川大学学报(医学版),2005；36(3)：318-321.
[17]Ntambi JM, Young-Cheul K. Adipoeyte differentiation and gene expression. J Nutr, 2000; 130(12):3122S-3126S.
[18]李冬菊,李良,吴江,等.去卵巢骨质疏松大鼠骨髓间充质干细胞体外成脂肪分化能力的研究.生物医学工程学杂志,2007；24(3)：641-645.
[2]郭艳,史大卓,陈可冀.中医药结合干细胞移植治疗心肌损伤性疾病的前景.新中医,2005；37(5)：88-89.
[3]张进,徐志伟,杜少辉,等.“精”学说与干细胞辨识.中医药学刊,2004；22(7)：1198-1200.
[4]张进,徐志伟,陈群,等.干细胞与中医基础理论中的先天之精学说.中国临床康复,2006：10(7)：189-192.
[5]张进,徐志伟.补肾法诱导间充质干细胞向神经方向分化研究.现代医院,2004；4(9)：15-17.
[1]Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell:entity or function?. Cell,2001; 105(7):829-841.
[2]Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries?. Nat Med, 2001; 7(4):393-395.
[3]Verfaillie CM, Pera MF, Lansdorp PM. Stem cells:hype and reality. Hematology Am Soc Hematol Educ Program,2002:369-391.
[4]Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science,1998; 282 (5391):1145-1147.
[5]Shamblott MJ, Axelman J, Wang SP, et al. Derivation of plutipotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA,1998; 95(23):13726-13731.
[6]Thomson JA. Embryonic stem cell lines derived from human blastocysts. Science,1998; 282(6):1145-1147.
[7]王启凤,王锋,蔡夸波.胚胎干细胞的研究进展及其应用.畜牧与兽医,2002；34(2)：40-42.
[8]Yamashita J, Itoh H, Hirashima M, et al. Flk-1 positive cells derived from embryonic stem cells serve as vascular progenitors. Nature,2000; 408(6808):92-96.
[9]Rolletschek A, Blyszczuk P, Wobus AM. Embryonic stem cell-derived cardiac, neuronal and pancreatic cells as model systems to study toxicological effects. Toxicol Lett, 2004; 149(1-3):361-369.
[10]Zur Nieden NI, Kempka G, Ahr HJ. In vitro diferentiation of embryoni stem cells into mineralized osteoblasts. Differentiation,2003; 71(1):18-27.
[11]Harper JM, Kfishnan C, Darman JS, et al. Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci USA,2004; 101(18):7123-7128.
[12]Zandstra PW,Bauwens C, Yin T, et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng,2003; 9(4):767-778.
[13]Kim D, Gu Y, Ishii M, et al. In vivo functioning and transplantable mature pancreatic islet-like cell clusters differentiated from embryonic stem cell. Pancreas,2003; 27(2): 34-41.
[14]赵惠萍,卢光锈,王绮如.两种条件培养基促进鼠胚胎干细胞分化为造血干细胞.中南大学学报,2007；32(1)：64-67.
[15]熊吉信,刘兆轩,刘小春,等.体外定向诱导小鼠胚胎干细胞向内皮细胞分化的研究.中国修复重建外科杂志,2007121(9)：994-996.
[16]Hubner K, Fuhrmann G, Christenson LK, et al. Derivation of oocytes from mouse Embryonic stem cells. Science,2003; 300(5623):1251-1256.
[17]Koay EJ, Hoben GM, Athanasiou KA, et al. Tissue engineering with chondrogenically differentiated human embryonic stem cells. Stem Cells,2007; 25(9):2183-2190.
[18]Lindvall 0. Stem cells for cell therapy in Parkinson disease. Pharmacol Res,2003; 47(4):279-287.
[19]McDonaid JW, Liu XZ, Qu Y, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med,1999; 5(12): 1410-1412.
[20]Kim JH, Auerliacch JM, Rodriguez Gomez JA, et al. Dopamine ueurons derived from embryonic stem cells funetion in all animal model of Parkinson'sdisease. Nature,2002; 418(6983):50-56.
[21]Cho YH, Kim DS, Kim PG, et al. Dopamine neurons derived from embryonic stem cells efficiently induce behavioral recovery in a Parkinsonian rat model. Bioehem Biophys RESC Commun,2006; 341(1):6-12.
[22]Min JY, Yang YK, Converse KL, et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol,2002; 92(1): 288-296.
[23]Laf lamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology,2007; 25(9):1015-1024.
[24]周其峰,何志旭,冯炼强,等.用胚胎干细胞诱导的造血干／祖细胞重建小鼠造血功能研究.热带医学杂志,2003；3(1)：9-11.
[25]Soria B, Roche E, Bema G, et al. Insulin-secreting cells derived from embryonic stem cells normaliz ESC glycerin in streptozotocin-induced diabetic mice. Diabet ESC,2000; 49(2):157-162.
[26]胡安斌,何晓顺,郑启昌,等.胚胎干细胞来源的肝细胞对急性肝功能衰竭小鼠的移植治疗作用.中华医学杂志,2006；86(46)：3281-3284.
[27]Burke ZD, Tosh D. Therapeutic potential of trailsdiferentiated cells. Clin Sci (Lond), 2005,108:309-321.
[28]Yang LY, Zheng JK, Wang CY, et al. Differentiation of adult human bone marrow mesenchymal stem cells into schwann-like cells in vitro. Chin J Traumatol,2005; 8(2): 77-80.
[29]Bianco P, Robey PG. Stem cells in tissue engineering. Nature,2001; 414(6859): 118-121.
[30]Coai S, Locateli F, Papadimitriou D, et al. Nuclear reprogramming and adult stem cell potential. Histol Histopathol,2005; 20(3):977-986.
[31]Lemoli RM, Bertolini F, Caneedda R, et al. Stem cell plasticity:time for a reappraisal?. Haematologica,2005; 90(3):360-381.
[32]Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors:stem cells and their niche. Cell,2004; 116(6):769-778.
[33]Pittenger M, Vanguri P, Simonetti D, et al. Adult mesenchymal stem cells:potential for muscle and tendon regeneration and use in gene therapy. J Musculoskelet Neuronal Interact,2002; 2(4):309-320.
[34]Cho KJ, Trzaska KA, Greco SJ, et al. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells,2005; 23(3):383-391.
[35]Doyonnas R, Iabmge MA, Sacco A. Hematopoietic contribution to skeletalmuscle regeneration by myelomonocytic precursors. Proc Natl Acad Sci USA,2004; 101(37): 13507-13512.
[36]Suzuki H, Taguchi T, TanakaH, et al. Neurezpheres induced from bone marrow stromal cells are multipotent for differentiation into neuron, astrocyte and oligodendrocyte phenotypes. Biochem Biophys Res Commun,2004; 322(3):918-922.
[37]杨慧敏,王顺和.神经干细胞定向分化为少突胶质细胞的实验研究.重庆医科大学学报,2007；32(8)：812-816.
[38]郭立达,王捷,夏冰．成体干细胞的可塑性研究.广东医学,2005；26(11)：1588-1590.
[39]Vescovi AL, RietzeR, Magli MC, et al. Hematopoietic potential of neural stem cells. Nat Med,2002; 8(6):535-537.
[40]Toma JG, Akhavan M, Fernandez KJ. Isolation of multipotent adult stem cells from the dermis of mamnlalian skin. Nat Cell Biol,2001; 3(9):778-784.
[41]Peterson B, Zhang J, lglesiasR, et al. Healing of critically sized femoral defects, using genetically modif-ied mezenchymal stem cells from human adipose tissue. Tissue Eng, 2005; 11(1-2):120-129.
[42]Ye F, Duvilie B, Scharfmann R. Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells. Diabetologia,2005; 48(2):277-281.
[43]Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation,2002; 105(1):93-98.
[44]Zuk PA, Zhu M, Mizuno H. Multilineage cells from human adipose tissue:implications for cell-based therapies. Tissue Eng,2001; 7(2):211-228.
[45]Lindberg K, Brown ME, Chavez HV, et al. In vitro propagation of human ocular surface epithelial cells for transplantation. Invest Ophthalmol Vis Sci,1993; 34(9):2672-2679.
[46]Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol,2005; 18(9):959-963.
[47]Yoon E, Dhar S, Chun DE, et al. In vivo osteogenie potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Engineering,2007; 13(3):619-627.
[48]Honma T, Homnou 0, lihoshi S, et al. Intravenous infusion of immaortalized human mesenehymal stem cells protects against iniury in a cerebral ischemia model in adult rat. Exp Neutrml,2006; 199(1):56-66.
[49]Conrad C, Huss R. Adult stem cell lines in regenerative medicine and reconstructive surgery. J Surg Res,2005; 124(2):201-208.
[50]Phinney DG. Lsakova L. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des,2005; 11(10):1255-1265.
[51]Lang D, Lu MM, Huang L, et al. Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature,2005; 433(7028):884-887.
[1]Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietie organs. Exp Hematol,1976; 4(5):267-274.
[2]Caplan AI. Mesenchymal stem cells. J Oflhop Res,1991; 9(5):641-650.
[3]Minguell.JJ, Eriees A, Conget P. Mesenehymal stem cells. Exp Biol Med (Maywod), 2001; 226(6):507-520.
[4]Huss R, Lange C, Weissinger EM, et al. Evidence of peripheral blood derived, plastic adherent CD34 hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells,2000; 18(4):252-260.
[5]Zvailer NJ, Marinova ML, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res,2000; 2(6):477-488.
[6]Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol,2000; 109(1):235-242.
[7]Noort WA, Kruisselbrink AB, Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice. Exp Hematol,2002; 30(8):870-878.
[8]Williams JT, Southerland SS, Souza J, et al. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg,1999; 65(1):22-26.
[9]Almeida PG, EI Shabrawy D, Porada C, et al. Differentiative potential of human metanephric mesenchymal cells. Exp Hematol,2002; 30(12):1454-1462.
[10]Pitenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science,1999; 284(5411):143-147.
[11]Niemeyer P, Seckinger A, Simank HG, et al. Allogenic transplantation of human mesenehymal stem cells for tissue engineering purposes:an in vitro study. Orthopade, 2004; 33(12):1346-1353.
[12]Deans RJ, Moseley AB. Mesenehymal stem cells:biology and potential clinical uses. Exp Hematol,2000,28(8):875-884.
[13]Gang EJ, Bosnakovski D, Figueiredo CA, et al. SSEA-4 identifies mesenchymal stem cells from bone marow. Blood,2007; 109(4):1743-1751.
[14]周进明,邹仲敏,郭朝华,等.小鼠骨髓间质干细胞的生物学特点及分化潜能鉴定.第三军医大学学报,2002；24(1)：58-61.
[15]周进明,邹仲敏,郭朝华,等.培养小鼠骨髓间充质干细胞及其移植后在体内的定位分布.中华放射医学与防护杂志,2002；22(3)：167-169.
[16]Ohgushi H, Caplan Al. Stem cell technology and bioceramics:from cell, to gene engineering. J Bimoed Mater Res,1999; 48(6):913-927.
[17]Conget PA, Minguell JJ. Phenotypical and functional Properties of human bone marow mesenchymal progenitorcells. Cell physiol,1999; 181(1):67-73.
[18]Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem,1997; 64(2):278-294.
[19]Bruder SP, Ricalton NS, Boynton RE, et al. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res,1998; 13(4):655-663.
[20]Hung SC, Chen NJ, Hsieh SL, et al. Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells,2002; 20(3):249-258.
[21]Bartholomew A, Sturgeon C, Siatska M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol,2002; 30(1): 42-48.
[22]Saito T, Kuang JQ, Bittira B, et al. Xenotransplant cardiac chimera:immune tolerance of adult stem cells. Ann Thorac Surg,2002; 74(1):19-24.
[23]Di Nicola M, Carlo SC, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002; 99(10):3838-3843.
[24]Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchyrmal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood, 2003; 101(9):3722-3729.
[25]Van VP, Falla N, Snoeck H, et al. Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using Anti-sca-1 monoclonal antibody and wheat germ agglutinin. Blood,1994; 84(3):753-763.
[26]Encina NR, Billotte WG, Hofmann MC. Immunomagnetic isolation of osteoprogenitors from human bone marrow stroma. Lab Invest,1999; 79(4):449-457.
[27]Woodbury D, Reynolds K, Black IB. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res,2002; 69(6):908-917.
[28]Lu KK, Armstrong SE, Ginnan R, et al. Adhesion-dependent activation of CaMKⅡand regulation of ERK activation in vascular smooth muscle. Am J Physiol Cell Physiol,2005; 289(5):C1343-1350.
[29]Sotiropoulou PA, Perez SA, Salagianni M, et al. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells, 2006; 24(2):462-471.
[30]Wang SJ, Bourguignon LY. Hyaluronan-CD44 promotes phospholipase C mediated Ca2+ signaling and cisplatin resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg,2006; 132(1):19-24.
[31]Stolzing A, Coleman N, Scutt A. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res,2006; 9(1):31-35. [32] Moussavi HF, Duwayri Y, Martin JA, et al. Oxygen effects on senescence in chondrocytes and mesenchymal stem cell:consequences for tissue engineering. Iowa Orthop J,2004; 24:15-20.
[33]Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochern,1997; 64(2):278-294.
[34]Colter DC, Class R, Digirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA, 2000; 97(7):3213-3218.
[35]Pochampally RR, Smith JR, Ylostalo J, et al. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanecd expression of OCT-4 and other embryonic genes. Blood,2004; 103(5):1647-1652.
[36]Qiu Q, Ducheyne P, Gao H, et al. Formation and differentition of three-dimensional rat marrow stromal cell culture on microcarriers in a rotating-wall vessel. Tissue Eng, 1998; 4(1):19-34.
[37]GLowacki J, Mizuno S, Greenberger JS. Perfusion enhances functions of bone marrow stromal cells in three dimensional culture. Cell Transplant,1998; 7(3):319-326.
[38]Kadiyala S, Young RG, Thide MA, et al. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant,1997; 6(2): 125-134.
[39]Nuttall ME, Patten AJ, Oliver DL, et al. Human trabecular bone cells are able to express both osteoblastic and adipocphenotype:implications for osteoponic disorders. J Bone Miner Res,1998; 13(3):371-382.
[40]Pilloni A, Bernard GW. The effect of hyalurmum on mouse intramembranous osteogenesis in vitro. Cell Tissue Res,1998; 294(2):323-333.
[41]Riew KD, Wright NM, Cheng S, et al. Induction of bone formation using are combinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calif Tissue Int,1998; 63(4):357-360.
[42]Mackay AM, Beck SC, Murphy JM, et al. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng,1998; 4(4):415-428.
[43]Rahfoth B, Weisser J, Sternkopf F, et al. Transplantation of allograft chondmcytes embeded in agarose gef into cartilage defects of rabbits. Osteoarthritis Cartilage, 1998; 6(1):50-65.
[44]Worster AA, Nixon AJ, Brower-Toland BD, et al. Effect of transforming growth factor betal on chondrogenic differentiation of cultured equine mesenehymal stem cells. Am J Vet Res,2000; 61(9):1003-1010.
[45]Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve,1995; 18(12):417-426.
[46]Tomita S, Li RK, Weisel RD, et al. Autolagous transplantation of bone marrow cells improves damaged heart function. Circulation,1999; 100(19Suppl):247-256.
[47]Wang JS, Shum Tim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty:feasibility and potential clinical advantages. J Thorac Cardiovasc Surg, 2000; 120(5):999-1005.
[48]Sanchez RJ, Song S, Cardozo PF, et al. Adult bone marrow stromal cells diferenfiate into neural cells in vitro. Exp Neurol,2000; 164(2):247-256.
[49]Kopon GC, Prockop DJ, Phinney IX. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA,1999; 96(19):10711-10716.
[50]Woodburry D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res,2000; 61(4):364-370.
[51]Kohyama J, Abe H, Shimazaki T, et al. Brain from bone:efficient"meta-differentiation" of marrow stromal-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation,2001; 68(4-5):235-244.
[52]Oh SH, Miyazaki M, Kouchi H. Hepatocyte growth factor induces differentiation of adult rat bone marrow cells into a hepatocyte lineage in vitro. Biochem Biophys Res Commun, 2000; 279(2):500-504.
[53]Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest,2002; 109(10): 1291-1302.
[54]Ouyang HW, Cao T, Zou XH, et al. Mesenchymal stem cell sheets revitalize nonviable dense grafts:implications for repair of large-bone and tendon defects. Transplantation, 2006; 82(2):170-174.
[55]朱付平,熊光仲,王万春,等.骨髓间充质干细胞在骨科中应用的研究进展.中国中医骨伤科杂志,2005；13(5)：78-81.
[56]Wakitani S, Imoto K, Yamamoto T, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage,2002; 10(3):199-206.
[57]Ahn JI, Terry Canale S, Butler SD, et al. Stem cell repair of physeal cartilage. J Orthop Res,2004; 22(6):1215-1221.
[58]Murphy JM, Fink DJ, Hunziker EB, et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum,2003; 48(12):3464-3474.
[59]Walsh CJ, Goodman D, Caplan A I, et al. Meniscus regeneration in a rabbit partial meniscectomy model. Tissue Eng,1999; 5(4):327-337.
[60]Brazelton TR, Rossi FMV, Keshet GL, et al. From marrow to brain:expression of neuronal pheno types jn adult mice. Science,2000; 290(5497):1775-1779.
[61]Mezzey E, Chandross KJ, Harta G, et al. Turning blood into brain:cells bearing neuronal antigens generated in vive from bone marrow. Science,2000; 290(5497):1779-1782.
[62]王晔,邓宇斌,那晓东.骨髓间充质干细胞在缺血性脑血管病治疗中的应用.国外医学脑血管疾病分册,2005；13(3)：203-205.
[63]Chen J, Li Y, Zhang R, et al. Combination therapy of stroke in rats with a nitric oxide donor and Human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res,2004; 1005(1-2):21-28.
[64]Park K, Eglitis MA, Mouradian MM. Protection of nigral neurons by GDNF-engineered marrow cells transplantation. Neurosci Res,2001; 40(4):315-323.
[65]胡煜,陈维信,阎影.MSCs在现代细胞治疗中的潜在作用.国际移植与血液净化杂志,2006；4(3)：35-37.
[66]Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci,2001; 938:221-230.
[67]韩永生,褚俊,翟志敏.骨髓间充质干细胞移植治疗心肌梗死的研究进展.国外医学：内科学分册,2004,11(31)：474-477.
[68]Strauer BE, Brehm M, Zeus T, et al. lntracoronary human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr,2001; 126(34-35):932-938.
[69]Tse HF, Kwong YL, Chan JKF, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet,2003; 61(9351):47-49.
[70]Noort WA, Kruisselbrink AB, in't Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+)cells in NOD/SCID mice. Exp Hematol,2002; 30(8):870-878.
[71]Koc ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol,2000; 18(2):307-316.
[72]Lee ST, Jang JH, Cheong JW, et al. Treatment of highrisk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by coinfusion of T cell-depleted haematopo ietic stem cells and culture-expanded marrow mesenchymal stem ceHs from a related donor with one fully mismatched human leucocyte antigen haplotype. BT JHaematol,2002; 118(4): 1128-1131.
[73]施小凤,傅晋翔,李军,等.间充质干细胞联合输注促进造血干细胞移植后的造血重建.中华器官移植杂志,2005；26(7)：411-414.
[74]Kodama S, Kuhtreiber W, Fujimura S, et al. Islet regeneration during reversal of autoimmune diabetes in NOD mice. science,2003; 302(5648):1223-1226.
[75]李立人,徐青.骨髓基质干细胞移植对糖尿病大鼠血糖的影响.苏州大学学报,2005；25(4)：584-585.
[76]Ikebukuro K, Adachi Y, Yamada Y, et al. Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow ceils via portal vein in rats. Transplantation,2002; 73(4):512-518.
[77]张传仓,朱为国,封志纯.自体骨髓干细胞移植治疗1型糖尿病的初步研究.广东医学,2004；25(12)：1398-1399.
[78]Theise ND, Badyes, Saxena R, et al. Derivation of hepatocytes from bone marrow cells in mice-after radiation induced myeloablation. Hepatology,2000; 31(1):235-240.
[79]She-Hoon OH, Heather M, Hatch BE. Hepaticoval stem cell in liver regeneration Seminars in cell and developmental. Biology,2002; 13(6):405-409.
[80]Wang JS, Shunrtim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty:Feasibility and potential clinical advantages. J Tholo Cardiova Surg, 2000; 120(5):999-1005.
[81]李莉,李燕芹.骨髓干细胞在肺纤维化中的作用及治疗.国际呼吸杂志,2006；26(7)：503-505.
[82]Yamada M, Kubo H, Kobayashi S, et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. Immunol,2004; 172(2):1266-1272.
[83]Rojas M, Xu J, Woods CR, et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Respir Cell Mol Biol,2005; 33(2):145-152.
[84]邓为民,李长虹,廖联明,等.成体骨髓源多能间充质干细胞体内分化为皮肤干细胞和皮肤组织.细胞生物学杂志,2003；25(2)：98-104.
[85]李海红,付小兵,王君,等.间充质干细胞分化为表皮附属细胞的初步实验研究.中国修复重建外科杂志,2006；20(6)：675-678.
[86]刘德伍,李国辉,胡翔,等.骨髓间充质干细胞复合胶原构建组织程皮肤修复皮肤缺损.中国临床康复,2005；9(2)：90-91.
[87]Vojtassak J, Danisovic L, Kubos M, et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocdnol Lett,2006; 27(12):134-137.
[1]张进,徐志伟,杜少辉,等.“精”学说与干细胞辨识.中医药学刊,2004；22(7)：1198-1200.
[2]张进,徐志伟.补肾法诱导间充质干细胞向神经方向分化研究.现代医院,2004；4(9)：15-17.
[3]张进,徐志伟,陈群,等.干细胞与中医基础理论中的先天之精学说.中国临床康复,2006110(7)：189-192.
[4]张建新.经络是干细胞系——兼论物种的起源与干细胞系的进化.中国中医基础医学杂志,2001；7(4)：17-20.
[5]张建新.待验证的揭示人体干细胞分布与分类的中医经络学说.中国中医基础医学杂志,2004；10(6)：13.
[6]刘柏炎,蔡先先.试论中医学精气与干细胞生物学的关系.湖南中医学院学报,2003；23(6)：29-30.
[7]郑展,王菊勇.肿瘤干细胞研究进展与扶助肾中精气抗癌.国际中西医肿瘤研究论坛论文专辑,2008；218-226.
[8]张莽,赵如同,赵艳明.成体组织干细胞与“肾先天之精”的相关性研究概述.中医杂志增刊,2006；47：234-235.
[9]肖党生,俞玲娣,余国友,等.试探干细胞与五行相生的相关性.浙江中医杂志,2007；42(11)：669-671.
[10]李利清,张新光,虞坚尔.中医藏象精气与干细胞关系研究.环球中医药,2010；3(1)：39-41.
[11]李显澎,范海蛟,樊粤光,等.补肾法诱导骨髓间充质干细胞定向成骨分化的研究进展.中医药导报,2007：13(12)：81-84.
[12]李瀚旻.“肝肾同源于脑”与肝肾本质研究.中医杂志,2000,41(2)：69-71.
[13]杜少辉,陈东风,李伊为,等.龟板对脑缺血大鼠骨髓间充质干细胞移植后转分化为神经元的影响.中华医学杂志,2005；85(3)：205-207.
[14]李瀚曼.中医再生医学概论.中华中医药学刊,2008；26(11)：2309-2312.
[15]冼绍祥,杨忠奇,汪朝晖,等.黄芪甲苷体外诱导骨髓间充质干细胞分化为心肌样细胞的实验研究.广州中医药大学学报,2007；24(1)：37-40.
[16]杨忠奇,冼绍祥,李南夷,等.三七总苷对骨髓间充质干细胞分化为心肌样细胞的作用：中药新药与临床药理,2006；17(4)：139-142.
[17]汪朝晖,冼绍祥.杨忠奇,等.人参总甙诱导骨髓间充质干细胞分化为心肌样细胞的实验研究.广州中医药大学学报,2006；23(2)：100-103.
[18]陈嘉,孙京臣,邹移海,等.丹酚酸B诱导骨髓间充质干细胞向心肌样细胞分化.第四军医大学学报,2007；28(23)：2152-2155.
[19]孙连胜,徐秀梅,郭茂娟,等.丹酚酸B体外干预骨髓间充质干细胞分化过程中cTnT的表达.天津中医药,2007；24(4)：318-320.
[20]范英昌,华声瑜,姚雅娟.丹酚酸B诱导体外培养大鼠骨髓基质细胞向心肌细胞分化的研究.天津中医学院学报,2005；24(1)：10-12.
[21]王金津,钱夕元,李雪,等.双龙方有效成分诱导干细胞分化过程中差异表达基因筛选和聚类分析.世界科学技术一中医药现代化,2007；9(3)：39-42.
[22]杨庆有,冼绍祥,孙慧茹,等.黄芪含药血清诱导骨髓间充质干细胞分化为心肌样细胞的实验研究.辽宁中医杂志,2008；35(6)：832-834.
[23]叶能胜,赵艳峰,张荣利,等.双龙方干预骨髓间质充质干细胞分化过程的蛋白表达.中成药,2007；29(1)：24-29.
[24]宋清,张晓文,户新政,等.参三七皂苷Rg预适应对5-氮胞苷诱导大鼠骨髓间充质干细胞向心肌细胞转化的干预.中国组织工程研究与临床康复,2007；11(24)：4693-4697.
[25]王和鸣,王力,李楠,等.巴戟天对骨髓基质细胞向成骨细胞分化影响的实验研究.福建中医学院学报,2004；14(3)：16-20.
[26]陈伟才,罗军.杜仲叶提取物诱导羊骨髓间充质干细胞成骨及抑制其成脂肪分化.中国组织工程研究与临床康复,2009；13(10)：1960-1964.
[27]刘海江,王小平,林娟,等.淫羊藿苷和黄芪苷I对骨髓基质细胞增殖及成骨能力的影响[J].中药材,2006(10)：1063-1065.
[28]郑良朴,李楠,王和鸣.补骨合剂对体外培养骨髓基质细胞分化影响的观察.福建中医学院学报,2003；13(6)：33-35.
[29]马慧萍,贾正平,张汝学,等.淫羊藿总黄酮含药血清促进骨髓间充质干细胞增殖与成骨性分化.中国骨质疏松杂志,2004；10(4)：420.
[30]程志安,宋少云,吴燕峰,等.健骨二仙丸介导间充质干细胞的成骨细胞定向分化诱导及其成骨活性.中国中医骨伤科杂志,2005；13(1)：8-11.
[31]曾建春,樊粤光,刘建仁,等.杜仲含药血清诱导骨髓间充质干细胞定向分化的实验研究.时珍国医国药,2009；20(9)：2316-2318.
[32]丘友如,陈玉兴.温阳通络胶囊含药血清对去卵巢大鼠骨髓间充质干细胞成骨活性的影响.实用医学杂志,2006；22(11)：1241-1242.
[33]范红旗,孙辉生,刘振旗,等.复方接骨中药对骨髓间充质干细胞体外增殖及向成骨细胞分化的影响.中国组织工程研究与临床康复,2007；11(10)：1818-1825.
[34]项鹏,夏文杰,张丽蓉,等.成人骨髓间质干细胞定向诱导为神经元样细胞的研究.中国病理生理杂志,2001；17(5)：385-387.
[35]肖庆忠,温冠媚,李浩威,等.麝香组分诱导成年大鼠骨髓间质干细胞体外定向分化为神经元样细胞的能力.中山医科大学学报,2002；23(6)：405-409.
[36]撒亚莲,李海标.三七总皂甙诱导骨髓间质干细胞分化为神经元样细胞.中山医科大学学报,2002；23(6)：409-410,437.
[37]郑国庆,王小同,邬伟,等.人参总皂苷体外诱导大鼠骨髓间充质干细胞分化为神经元样细胞.中华中医药学刊,2008；26(6)：1257-1259.
[38]蔡光先,林琳,刘柏炎,等.地黄多糖诱导骨髓间充质干细胞分化为神经样细胞的效应.中国临床康复,2005；9(17)：46-47.
[39]夏文杰,陈振光,张丽蓉,等.隐丹参酮诱导骨髓间质干细胞分化为神经元样细胞的实验研究.中国中西医结合杂志,2002；22(12)：921-924.
[40]夏文杰,项鹏,张丽蓉,等.丹参酮ⅡA定向诱导骨髓间质干细胞分化为神经元样细胞的研究.中国病理生理杂志,2003：19(7)：865-869.
[41]撒亚莲,李海标.川芎嗪诱导大鼠骨髓间质干细胞分化为神经元样细胞的研究.解剖学报, 2003；34(5)：514-517.
[42]向平,李海标.黄连素诱导大鼠骨髓间质干细胞分化为神经元样细胞.中国病理生理杂志,2004；20(1)：51-53.
[43]贾延劫,杨于嘉.宋元宗.黄芩甙体外诱导大鼠骨髓基质细胞成为神经细胞.中国病理生理杂志,2002：18(3)：247-249.
[44]余勤,连俊兰,郭莹.丹参注射液诱导骨髓间质干细胞分化为神经元样细胞的实验研究.中国中西医结合急救杂志,2006；13(4)：210-213.
[45]常宏,蒋绍艳,史玉朋,等.丹参注射液诱导大鼠骨髓间充质干细胞分化为神经元样细胞的研究.中国药房,2008；19(30)：2323-2325.
[46]刘金保,董晓先,董燕湘,等.多种中药成分诱导大鼠骨髓间质干细胞转变为神经元样细胞.中国药物与临床,2003；3(3)：234-236.
[47]王勇,陆长青,王凡.黄芪诱导大鼠骨髓间充质干细胞分化为神经样细胞的研究.四川解剖学杂志,2006；14(1)：5-8.
[48]董立华,王勇,陆长青.黄芪诱导大鼠骨髓间充质干细胞分化为神经样细胞的研究.四川大学学报(医学版),2007：38(3)：417-420.
[49]邝学媚,廖欣,杜少辉,等.三甲复脉汤含药血清体外诱导成年大鼠骨髓间充质干细胞分化为神经元.中国临床康复,2005；9(30)：53-55.
[50]黄洁,杜少辉,张宜,等.牛珀至宝微丸诱导成年大鼠骨髓间充质干细胞分化为神经元的研究.江西中医药,2003；34(10)：40-41.
[51]杜少辉,陈东风,李伊为,等.龟板对脑缺血大鼠骨髓间充质干细胞移植后转分化为神经元的影响.中华医学杂志,2005：85(3)：205-207.
[52]姚晓黎,张成,卢锡林,等.参芪扶正注射液诱导成人问质干细胞治疗脑梗塞的实验研究.中国中西医结合杂志,2005；25(7)：629-632.
[53]汤治黎,章汉平,李源,等.丹参注射液诱导大鼠骨髓间充质干细胞分化为成软骨细胞的研究.湖北中医杂志,2008：30(6)：11-12.
[54]肖鲁伟,武中庆,季卫锋,等.右归饮诱导胎兔骨髓基质细胞向软骨细胞分化的实验研究.中国中医药科技,2005；12(3)：154-155,175.
[55]李楠,王和鸣,李文顺,等.龟鹿二仙胶汤含药血清对兔体外BMSCs向软骨细胞分化的干预作用.上海中医药大学学报,2007；21(6)：58-61.
[56]吴追乐,刘献祥,李西海,等.透骨消痛颗粒诱导骨髓间充质干细胞向软骨细胞的分化.中国组织工程研究与临床康复,2009；13(33)：6456-6460.
[57]王大伟,潘华,李红波,等.三七总皂苷对酒精诱导骨髓基质干细胞分化影响的实验研究.中国组织工程研究与临床康复,2008；12(8)：1410-1413.
[58]闫金松,魏志杰,王冰,等.中药祛脂素对再生障碍性贫血患者骨髓间充质干细胞脂肪分化的干预.中国组织工程研究与临床康复,2008；12(25)：4873-4876.
[59]徐无忌,庄洪.骨康含药血清对大鼠骨髓间充质干细胞成脂分化的影响.中国组织工程研究与临床康复,2008；12(43)：8434-8438.
[1]Matsubara T, Tsutsumi S, Pan H, et al. A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix. Bioehem BiophysRes Commun, 2004; 313(3):503-508.
[2]Hashimoto J, Kariya Y, Miyazaki K. Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332). Stem Cells, 2006; 24(11):2346-2354.
[3]Chen XD, Dusevich V, Feng JQ, et al. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res,2007; 22(12):1943-1956.
[4]万千雪.胞外基质、细胞因子及机械刺激对大鼠骨髓间充质干细胞增殖的调节作用[硕士学位论文].重庆：重庆大学,2008.
[5]周炳荣,华子春,胡勤刚,等.P-6对人骨髓间充质干细胞黏附和增殖特性的影响.口腔医学研究,2004；20(1)：19-21.
[6]Jager M, Feser T, Denck H, et al. Proliferation and osteogenic differentiation of mesenchymal stem cells cultured onto three different polymers in vitro. Ann Biomed Eng, 2005; 33(10):1319-1332.
[7]Larsen M, Artym VV, Green JA, et al. The matrix reorganized:extracellular matrix remodeling and integrin signaling. Curt Opin Cell Biol,2006; 18(5):463-471.
[8]Kotev Emeth S, Pitaru S, Pri Chen S, et al. Establishment of a rat long-term culture expressing the osteogenic phenotype:dependence on dexamethasone and FGF-2. Connect Tissue Res,2002; 43(4):606-612.
[9]Solchaga LA, Penick K, Porter JD, et al. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol, 2005; 203(2):398-409.
[10]Scutt A, Bertram P. Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif Tissue Int,1999; 64(1):69-77.
[11]Hankemeier S, Keus M, Zeichen J, et al. Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2:potential implications for tissue engineering of tendons and ligaments. Tissue Eng,2005; 11(1-2):41-49.
[12]Locklin RM, wiliamson MC, Beresford JN, et al. In vitro effects of growth factors and dexamethasone on rat marrow stroml cells. Clin Orthop,1995; 313(1):27-35.
[13]俞猛,徐万鹏,于方,等.TGF-β1和bFGF对骨髓基质干细胞增殖、分化的影响.中国骨肿瘤骨病,2006；5(6)：321-325.
[14]Locklin RM, Oreffo RO, Triffitt JT. Effects of TGF beta and bFGF on the differentiation of human bone marrow stromal fibroblasts Cell. Biol Int,1999; 23(3):185-194.
[15]Warzecha J, Gottig S, Brflning C, et al. Sonic hedgehog protein promotes proliferation and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro. J Orthop Sci,2006; 11(5):491-496.
[16]De Boer J, Wang HJ, Van Blitterswijk C. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng,2004; 10(3-4):393-401.
[17]刘岐焕,程范军,陈龙,等.粒细胞集落刺激因子对小鼠骨髓间充质干细胞的作用.武汉大学学报(医学版),2007；28(3)：336-340.
[18]Mayr-Wohlfart U, Kessler S, Knochel W, et al. BMP-4 of Xenopus laevis stimulates differentiation of human primary osteoblast-like cells. J Bone Joint Surg Br,2001; 83(5): 777-784.
[19]Tamama K, Fan VH, Grifith LG, et al. Epidermal growth factor as a candidate for exvivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells,2006; 24(3):686-695.
[20]张海红,侯相麟,王小蕊.促红细胞生成素对人骨髓间充质干细胞增殖和细胞周期的影响.中国组织工程研究与临床康复,2008；12(29)：5671-5674.
[21]柴海霞,程范军,高清平,等.促血小板生成素对小鼠骨髓干细胞增殖的影响.中华器官移植杂志,2008；29(2)：86-89.
[22]张卫兵,洪光祥,康皓.富血小板血浆对兔骨髓间充质干细胞增殖的作用.中国组织工程研究与临床康复,2008；12(34)：6639-6642.
[23]Muller I, Kordowich S, Holzwarth C, et al. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy,2006; 8(5):437-444.
[24]Doucet C, Ernou I, Zhang Y, et al. Platelet lysates promote mesenchymal stem cell expansion:a safety substitute for animal serum in cell-based therapy applications. J Cell Physiok,2005; 205(2):228-236.
[25]Gruber R, Karreth F, Kandler B, et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets,2004; 15(1):29-35.
[26]Krampera M, Pasini A, Rigo A, et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells:inducing cell expansion and reversibly preventing multilineage differentiation. Blood,2005; 106(1):59-66.
[27]Carcamo-Orive I, Tejados N, Delgado J, et al. ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential. Exp Cell Res,2008; 314(8):1777-1788.
[28]Levy 0, Dvir T, TsurGang 0, et al. Signal transducer and activator of transcription 3-A key molecular switch for human mesenchymal stem cell proliferation. Int J Biochem Cell Biol,2008; 40(11):2606-2618.
[29]Bocker W, Docheva D, Prall WC, et al. IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells. J Mol Med,2008; 86(10):1183-1192.
[30]De Boer J, Siddappa R, Gaspar C, et al. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone,2004; 34(5):818-826.
[31]Colvin GA, Lambert JF, Carlson JE, et al. Rhythmicity of engraftment and altered cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static cultures. In Vitro Cel Dev Biol Anim,2002; 38(6):343-351.
[32]Chen XD, Dusevich V, Feng JQ, et al. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res,2007; 22(12):1943-1956.
[33]Colvin GA, Lambert JF, Carlson JE, et al. Rhythmicity of engraftment and altered cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static cultures. In Vitro CelDev Biol Anim,2002; 38(6):343-351.
[34]Song G, Ju Y, Soyama H, et al. Regulation of cyclic longitudinal mechanical stretch on proliferation of human bone marrow mesenchymal stem cells. Mol Cell Biomech,2007; 4(4):201-210.
[35]黎润光,邵景范,魏明发,等.牵张应力对人骨髓间充质干细胞增殖及细胞周期的影响.中国组织工程研究与临床康复,2007；11(7)：1247-1251.
[36]李正章,程应樟,吴险峰,等.周期性压力培养对免骨髓问充质干细胞增殖的影响.中国组织工程研究与临床康复,2009；13(19)：3628-3632.
[37]徐巧玲,罗二平,路丽华.恒磁场对大鼠骨髓间充质干细胞增殖的影响.中国医学物理学杂志,2009；26(1)：999-1002.
[38]方真华,吴华,马伟明,等.50Hz电磁场对小鼠骨髓间充质干细胞增殖的影响.中华物理医学与康复杂志,2004；26(1)：1-4.
[39]Liedert A, Kaspar D, Blakytny R, et al. Signal transduction pathways involved in mechanotransduction in bone cells. Bioehem Biophys Res Commun,2006; 349(1):1-5.
[40]Ko KS, McCulloch CA. Intercellular mechanotransduction:cellular circuits that coordinate tissue responses to mechanical loading. Bioehem Biophys ResBiophys Res Commun, 2001; 285(5):1077-1083.
[41]Li YJ, Batra NN, You L, et al. Oscillatory fluid flow affects human marrow stromal cell proliferation and differentiation. J Orthop Res,2004; 22(6):1283-1289.
[42]戚孟春,胡静,邹淑娟,等.机械力学对体外骨髓间充质干细胞的影响.华西口腔医学杂志,2005；23(2)：110-113.
[43]Riddle RC, Taylor AF, Genetos DC, et al. MAP kinase and calcium signaling mediate fluid flow-induced human mesenchymal stem cell proliferation. Am J Physiol Cell Physiol, 2006; 290(3):C776-C784.
[44]Simmons CA, MatlisS, Thornton AJ, et al. Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech,2003; 36(8):1087-1096.
[45]赵东明,吴华,黄珊珊,等.电磁场激活细胞外信号调节激酶通路在骨髓间充质干细胞增殖与分化成骨中的作用.中华物理医学与康复杂志,2008；30(8)：515-518.
[46]郭少三,黄畅,韩大良,等.人参茎叶皂苷对体外条件下小鼠骨髓间充质干细胞和粒一巨噬系祖细胞增殖的影响.中医药导报,2007；13(6)：6-9,14.
[47]韩大良,黄畅,郭少三,等.人参皂苷Rbl对体外条件下小鼠骨髓间充质干细胞和粒一巨噬系祖细胞增殖的影响.中华中医药学刊,2008；26(6)：1192-1193.
[48]王力,吴鑫,卢新政,等.人参皂苷Rgl对培养大鼠骨髓间充质干细胞增殖影响的机制研究.中国药理学通报,2007；23(11)：1480-1484.
[49]吴涛,徐俊昌,南开辉,等.淫羊藿苷促进羊骨髓间充质干细胞的增殖和成骨分化.中国组织工程研究与临床康复,2009；13(19)：3725-3729.
[50]李志泉,冼绍祥,汪朝晖,等.三七总皂苷对骨髓间充质干细胞增殖和向心肌样细胞分化的影响.广州中医药大学学报,2007；24(6)：470-474.
[51]许春娇,翦新春,郭峰华,等.黄芪多糖对犬骨髓基质干细胞增殖及超微结构的影响.华西口腔医学杂志,2007；25(5)：432-436.
[52]修忠标,林建华.鹿茸多肽对人骨髓间充质干细胞体外增殖的影响.福建中医学院学报,2005；15(1)：34-37.
[53]李熙灿,周健洪,黎晖,等.荜提取物对大鼠骨髓间充质干细胞的增殖作用及与化学官能团的关系.中药材,2005；28(7)：570-573.
[54]马慧萍,贾正平,张汝学,等.淫羊藿总黄酮含药血清促进骨锈间充质干细胞增殖与成骨性分化.中国骨质疏松杂志,2004；10(4)：420-422,428.
[55]董群伟,孙奋勇,王华,等.牛膝含药血清对体外培养人间充质干细胞增殖与分化的影响.广东药学院学报,2006；22(2)：185-187.
[56]陈薇,曾和平,王春艳,等.中药龟板提取物化学成分及其调控鼠骨髓间充质干细胞增殖活性的实验研究.化学学报,2007；65(3)：265-270.
[57]张越华,曾和平,陈东风,等.龟板脂肪酸调控鼠骨髓间质干细胞增殖作用.生物工程学报,2007；23(6)：304-309.
[58]黎晖,李春,陈东风,等.龟板含药血清促进骨髓间充质干细胞骨形态发生蛋白4的表达.解剖学报,2007；38(3)：304-309.
[59]郑庆元,余伟吉,杜少辉,等.龟板含药血清对骨髓间充质干细胞增殖细胞核抗原表达的影响.中华中医药学刊,2008；26(2)：268-270.
[60]陈薇,曾和平,王婷婷.中药四物汤提取物调控鼠骨髓间充质干细胞增殖活性的化学成分分析.分析化学研究报告,2008；36(4)：459-466.
[61]周晓东,宋宇轩,张丽君,等.桂附地黄丸对骨髓基质干细胞增殖能力的影响.家畜生态学报,2005；26(2)：56-58.
[62]张文海,李秀兰,张杨,等.中药生肌液对兔骨髓间充质干细胞增殖活性的影响.中国中西医结合外科杂志,2007；13(2)：146-149.
[63]曾意荣,樊粤光,刘红,等.补肾活血中药对大鼠骨髓间充质干细胞体外增殖的影响.中药新药与临床药理,2007；18(2)：93-96.
[64]范红旗,孙辉生,刘振旗,等.复方接骨中药对骨髓间充质干细胞体外增殖及向成骨细胞分化的影响.中国组织工程研究与临床康复,2007；11(10)：1818-1821,182.
[65]陈凯佳,刘小斌,邱仕君,等．强肌健力口服液含药血清对大鼠骨髓间充质干细胞体外增殖的影响.中国中医药信息杂志,2008；15(2)：23-25.
[66]王明宁,林洪,胡琳,等.香丹注射液对大鼠骨髓间充质干细胞的增殖作用.华西药学杂志,2007：22(3)：304-305.
[67]王明宁,胡琳,胡火珍,等.四种中药注射液对大鼠骨髓间充质干细胞增殖作用的影响.四川动物,2008；27(6)：1130-1132.
[68]王明宁,胡琳,马祁生,等.刺五加注射液对骨髓间充质干细胞增殖的影响.青海医学院学报,2008；29(2)：116-118.
[69]王明宁,胡琳,侯成荣,等.刺五加、黄芪、参麦、生脉注射液对大鼠骨髓间充质干细胞增殖的影响比较.山东医药,2009；49(6)：38-39.
[70]王明宁,胡琳.低氧环境中几种中药注射液对大鼠骨髓间充质干细胞增殖的影响.高原医学杂志,2009；19(2)：7-9.
[1]Lisignoli G, Remiddi G, Cattini L. An elevated number of differentiated osteoblast colonies can be obtained from rat bone marrow stromal cells using a gradient isolation procedure. Connect Tissue Res,2001; 42(1):49-57.
[2]项平,黄锦桃,撒亚莲,等.大鼠骨髓间充质干细胞的培养及鉴定.蚌埠医学院学报,2005；30(1)：1-4.
[3]Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation,1968; 6(2):230-247.
[4]Colter DC, Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA, 2000; 97(7):3213-3218.
[1]汪鸿宇,俞仲毅,李仪奎,等.血清药理实验中不同动物种属血清对脾脏淋巴细胞的影响.中国中医药科技,2001：8(3)：185.
[2]刘成海,刘成,刘平.抗肝纤维化有效中药复方血清药理学方法探讨.中国实验方剂学杂志,1998-4(2)：16-19.
[3]曹俊,张红梅,王旋.中药血清药理学研究概况.中国中医药信息杂志,2002；9(1)：80-92.
[4]王力倩,李仪奎,符胜光,等.血清药理学方法研究探讨.中药药理与临床,1997；13(3)：29-31.
[5]李仪奎.中药血清药理学试验方法的若干问题.中药新药与临床药理,1999；10(2)：95-97.
[6]王宁生.关于血清药理学的若干思考.中国新药与临床药理,1999；10(5)：263-266.
[7]陈奇.中药药理研究方法学.北京：人比卫生出版社,第一版,1993：1103.
[8]王吕俊.扶正抗癌方药物血清对人肝癌细胞增殖的影响.中西医结合肝病杂志,1997；7(4)：214-216.
[9]刘成海.扶正化瘀复方药物血清对大鼠肝贮脂细胞增殖及胶原合成的影响.中国实验方剂学 杂志,1996；2(2)：16-19.
[10]李仪奎,吴健宇.血清药理实验中采血时间的通法方案.中国药理学通报,1999；15(6)：569-570.
[11]蒙一纯,丁霞,贲长恩.中药血清药理学应用研究展望.北京中医药大学学报,1999；22(4)：42-44.
[12]崔晓兰,贺玉琢,高英杰,等.中药复方血清药理方法学探讨.中国实验方剂学杂志,1999；5(3)：36-37.
[13]徐海波,吴清和.中药血清药理学实验方法的探讨.中国中医药科技,2000；7(1)：43-44.
[14]周明眉,杨奎,姜远平,等.中药血清药理学的方法学研究——反应体系中含药血清加入量的研究.中药药理与临床,1998；14(6)：43-44.
[15]吴健宇,李仪奎,符胜光,等.补阳还五汤保护自由基损伤血管内皮细胞的血清药理实验方法的建立.中药药理与临床,1999；15(1)：45-46.
[16]管淑玉,苏薇薇.何首乌的化学成分和药理作用研究进展.中南药学,200816(4)：454-455.
[17]陈计,夏炎兴,杨秋美,等.何首乌吸收成分对大鼠二倍体细胞生长和传代的影响.上海中医药杂志,1995；8：41-42.
[18]金哲雄,金政.何首乌对缺氧培养心肌细胞保护作用的实验研究.时珍国医国药,2006；17(8)：1454-1456.
[19]邓响潮,黄俊柅,练志文,等.何首乌不同提取物对小鼠脾淋巴细胞的增殖作用.中国现代药物应用,200812(8)：1-3.
[20]熊平源,胡艺兰,郭凯文,等.何首乌对小鼠腹腔巨噬细胞功能的影响.数理医药学杂志,2007；20(3)：370-371.
[21]胡存华,赵立波,王晓敏,等.THSG增强正常血管内皮细胞抗氧化作用研究.医药导报,2007：26(2)：138-139.
[22]刘莉萍,杨耀防,何明,等.THSG对人脐静脉血管内皮细胞缺氧复氧损伤的影响.中国组织工程研究与临床康复,2009；7(13)：1320-1323.
[23]王文权,张韶辉,赵立波,等.THSG抑制人乳腺癌MCF-7细胞增殖及对PDK/Akt信号通路的影响.肿瘤,2009；29(1)：26-30.
[24]Kinnaird T, Stabile E, Burnett MS, et al. Marrow derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res,2004; 94(5):678-685.
[25]Neuhuber B, Timothy Himes B, Shumsky JS, et al. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res,2005; 1035(1):73-85.
[26]Sze SK, de Kleijn DP, Lai RC, et al. Elucidating the secretion proteome of human embryonic stem cellderived mesenchymal stem cells.Mol Cell Proteomics,2007; 6(10): 1680-1689.
[27]Lee RH, Kim B, Choi I, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem,2004; 14(4-6): 311-324.
[28]Takahashi M, Li TS, Suzuki R, et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol,2006; 291(2):H886-H893.
[29]Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation2independentmechanisms. Am J Physiol Renal Physiol,2005; 289(1):F31-F42.
[30]Xu M, Uemura R, Dai Y, et al. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol,2007; 42(1):441-448.
[31]Zhang M, Mal N, Kiedrowski M, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J,2007; 21 (12): 3197-3207.
[32]Martin FH, Suggs SV, Langley KE, et al. Primary structure and functional expression of rat and human stem cell factor DNA. Cell,1990; 63(1):203-211.
[33]Anderson DM, Lyman SD, Daird A, et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell,1990; 63(1):235-243.
[34]Inenberger MI, Jacobsen FW, Bennett LG, et al. Stem cell factor and hematopoiesis.Blood,1997; 90(4):1345-1364.
[35]潘明,张鸣.干细胞因子研究概况.国外医学临床生物化学与检验学分册,2005；26(9)：597-599.
[36]Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor and mast cells what each is teaching us about the others. AmJ Pathol,1993; 142(4):965-947.
[37]Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infracted heart, improving function and survival. Proc Natl Acad Sci,2001; 98(18): 10344-10349.
[38]Kocher AA, Schuster MD, SzbolcsML, et al. Neovascularization of ischemic myocardium by human bone marrow derived angioblasts prevents cardio myocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med,2001; 7 (4):430-436.
[39]Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature,2001; 410(6829):701-705.
[40]Takano H, Ohtsuka M, Akazawa H, et al. Pleiotropic effects of cytokines on acute myocardial infarction:G-CSF as a novel therapy for acute myocardial infarction. Current pharmaceutical design,2003; 9(14):1121-1127.
[41]Dormady SP, Bashayan 0, Dougherty R, et al. Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. Journal of hematotherapy &stem cell research,2001; 10(1):125-140.
[42]Woldbaek PR, Hoen IB, Christensen G, et al. Gene expression of colony stimulating factors and stem cell factor after myocardial infarction in the mouse. Acta physiologica Scandinavica,2002; 175(3):173-181.
[1]国家药典委员会.中国药典.北京：化学工业出版社,2005,第1版：215.
[2]龚莉,向大雄,隋艳华.黄精醇提物对心肌缺血大鼠心脏组织中AST、CK、LDH等活性及心肌 坏死病理变化的影响.中医药导报,2007；13(6)：99-101.
[3]胡国柱,聂荣庆,肖移生.黄精多糖对新生大鼠大脑皮层神经细胞缺氧性凋亡的影响.中药药理与临床,2005；21(4)：37-39.
[4]文珠,肖移生,唐宁.黄精多糖对神经细胞的毒性及抗缺氧性坏死和凋亡作用研究.中药药理与临床,2006；22(2)：29-31.
[5]赵小贞,王玮,康仲涵.黄精口服液对血管性痴呆大鼠行为和海马星形胶质细胞的影响.中国行为医学科学,2008；17(10)：875-877.
[6]Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells and stromal cell. J Cell Physiol, 1998; 176(1):57-66.
[7]Dormady SP, Bashayan 0, Dougherty R, et al. Immortalized multipotential mesenchymal stem cells and the hematopoietic microenvironment. J Hematother Stem Cell Res,2001; 10(1):125-140.
[8]Fruehauf S, Veldwi jk MR, Kramer A, et al. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cell from steady-state bone marrow and peripheral blood mobilized following GCSF-suprcrted chemotherapy. Stem Cells,1998; 16(4):271-279.
[9]Watari K, Asano S, Shirafuji N, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoloassay. Blood,1989; 73(1):117-20.
[10]李洪,许志恩,李维,等.粒细胞集落刺激因子对大鼠骨髓间充质干细胞增殖的影响.中国脑血管病杂志,2008；5(10)：461-465.
[1]国家药典委员会.中国药典.北京：化学工业出版社,2005,第1版：55-56.
[2]陈彩英,詹若挺,陈蔚文.巴戟天的药理研究进展.中药新药与临床药理,2009；20(3)：291-293
[3]林励、徐鸿华.不同年龄巴戟天微量元素、氨基酸及糖含量测定.广州中医学院学报,1992；9(3)：160-163.
[4]李楠,王和鸣,林旭.巴戟天对成骨细胞生物学特性影响的实验研究.中国医药学报,2004：19(12)：726-728.
[5]李楠,王和鸣,郭素华,等.巴戟大多糖及其水提取物对体外培养成骨细胞活性的影响.中国组织工程研究与临床康复,2007；7(2)：4570-4572.
[6]王和鸣,王力,李楠.巴戟天对骨髓基质细胞向成骨细胞分化过程Cbf α1表达的影响.中国中医骨伤科杂志,2004；12(6)：22-26,29.
[7]李楠,王和鸣,郭素华,等.巴戟天多糖对体外培养成骨细胞核心结合因a ImRNA表达的影响.中华中医药杂志,2007；22(8)：517-519.
[8]李楠,王和鸣,郭素华,等.巴戟天多糖含药血清对体外培养成骨细胞凋亡的保护作用观察.中国骨伤,2008：21(1)：39-41.
[9]张贺鸣,韩联合,冯国清.巴戟天对培养乳鼠心肌细胞缺氧复氧损伤的防护作用.河南中医学院学报,2005；20(3)：20-21.
[10]韩联合,冯国清,张贺鸣.巴戟天正丁醇提取物对乳鼠心肌细胞缺氧／复氧损伤后炎性细胞 因子的影响.中国医院药学杂志,2008；28(17)：1450-1453.
[11]潘新宇,牛岭.巴戟天对过度训练大鼠心肌细胞凋亡的影响.中国临床康复,2006；10(3)：102-103.
[12]黄涛,李楠,王和鸣.巴戟天多糖对体外培养兔软骨细胞增殖的影响.北京体育大学学报,2007；30(9)：1216-1218.
[13]王奎鹏,冯国清,胡香杰.巴戟天寡糖对成肌细胞增殖及分化的影响.中国药理通讯,2009；26(2)：43.
[14]赵辉,梁惠宾.巴戟天对人体及小鼠淋巴细胞增殖的影响.中医杂志,2002；43(1)：57-58.
[15]尹永英.巴戟天对脐血CD34细胞体外扩增的影响.现代预防医学,2006；33(8)：1351.
[16]潘文灏,许志超,赵余庆.菟丝子的生物活性与临床应用研究进展.亚太传统医药,2008；4(4)：47-51.
[17]谢雁鸣,秦林林,于向东,等.骨碎补、淫羊藿、菟丝子总黄酮对成骨细胞体外培养影响的比较研究.中华中医药杂志,2005；12(7)：22-23.
[18]王晓敏,王建红,伍庆华,等.菟丝子黄酮对去势雌性大鼠血清雌激素水平和血管平滑肌细胞的影响.天津医药,2005；33(10)：650-651.
[19]王晟,秦达念.菟丝子总黄酮对大鼠睾丸曲细精管无血清培养所致细胞凋亡的保护作用.中国药理学通报,2006；22(8)：984-987.
[20]真国辉,姜波,包永明,等.菟丝子黄酮类组分对H202损伤PCI2细胞的保护作用.中药材,2006；29(10)：1051-1055.
[21]刘悦,季晖,蔡曼玲.蛇床子、菟丝子及其复方对体外培养成骨细胞和破骨细胞的影响及血清药理学研究.中国药理通讯,2004；21(3)：14.
[22]沈骅睿,吕文科,胡晓梅.菟丝子定向诱导成骨细胞向神经元细胞转化的研究.中华实用中西医,2005；18(21)：1549-1551.
[23]李志刚,姜波,包永明,等.菟丝子提取物对MPP十诱导的PCI2细胞凋亡的保护作用.中成药,2006；28(2)：219-222.
[24]王利华,卜鹏程,包永明.菟丝子提取物对活性氧引起已分化的PCI2细胞损伤的保护作用.细胞生物学,2005；27：69-72.
[25]刘建辉,姜渡,包永明,等.菟丝子提取物在PCI2细胞株中的神经营养样作用.生物化学与生物物理进展,2003；30(2)：226-227.
[26]Prevost JM, Farrell PJ, Iatrou K, et al. Determinants of the functional interaction between the soluble GM-CSF receptor and the GM-CSF receptor beta-subunit. Cytokine, 2000; 12(3):187-197.
[27]Hartung T. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol,1998; 5(3):221-225.
[28]Kimber SJ. Leukaemia inhibitory factor in implantation and uterine biology. Reproduction,2005; 130(2):131-145.
[29]Ni H, Ding NZ, Harper MJ, et al. Expression of leukemia inhibitory factor receptor and gp130 in mouse uterus during early pregnancy. Mol Reprod Dev,2002; 63(2):143-150.
[30]Zvonic S, Baugh JE. Arbout-Rcily P, et al. Cross-talk among gp130 cytom in adipoeytes. Biochem Mol Biol,2005; 280(40):33856-33863.
[31]Liu T, Gao Y, Sakamoto K, et al. BMP-2 promotes differentiation of osteoblasts chondroblasts in Runx2-deficient cell lines. J Cell Physiol,2007; 211(3):728-735.
[32]Freyria AM, Courtes S, Mallein-Gerin F. Differentiation of aduh human mesenchymal stem cells:chondrogenic effect of BMP-2. PatholBiol,2008; 56:326-333.
[33]Mayr-Wohlfart U, Kessler S, Knochel W, et al. BMP-4 of Xenopus laevis stimulates differentiation of human primary osteoblast-like cells. J Bone Joint Surg Br,2001; 83(5): 777-784.
[1]王新生,崔慧先,马海东,等.黄芪诱导骨髓间充质干细胞向神经干细胞分化.解剖学杂志,2007；30(5)：534-537.
[2]王勇,陆长青,王凡.黄芪诱导大鼠骨髓间充质干细胞分化为神经样细胞的研究.四川解剖学杂志,2006；14(1)：5-8.
[3]邹萍,胡翔,刘德伍.黄芪诱导人骨髓间充质干细胞向表皮样细胞的分化.中国组织工程研究与临床康复,2009；13(36)：7099-7102.
[4]陈阿琴,杨志刚,俞颂东,等.黄芪多糖药理作用研究进展.中国兽药杂志,2005；35(9)：33.
[5]刘毅,王文健,陈伟华,等.黄芪多糖对3T3-L1前脂肪细胞增殖和分化的影响.中西医结合学报,2007；5(4)：421-426.
[6]李萍,何秀娟,张颖一,等.黄芪多糖对细胞增殖及血管内皮细胞与白细胞粘附作用的影响.中国病理生理杂志,2004,20(9)：1677-168.
[7]张霄翔,杨雁,陈敏珠.黄芪多糖对HSC-T6细胞增殖及胶原产生的影响.中国临床药理学与治疗学,2003；8(6)：645-647.
[8]房信胜,穆象山,周红英,等.黄芪皂苷和黄芪多糖对大鼠肾脏系膜细胞增殖的影响.时珍国医国药,2008；19(6)：1448-1449.
[9]许春娇,翦新春,郭峰华,等.黄芪多糖对犬骨髓基质干细胞增殖及超微结构的影响.西口腔医学杂志,2007；25(5)：432-436.
[1]朱也君.加味左归丸治疗卵巢早衰继发性闭经30例.辽宁中医杂志,2008；35(3)：407-408.
[2]于淑云,刘玉蕾.加昧左归丸治疗更年期综合征160例.陕西中医,2007：28(9)：1178-1179.
[3]李素琴,张宏亮.左归丸加减治疗绝经前后诸症54例.四川中医,2005；23(6)：75.
[4]张君满.左归丸加减在妇科疾病中的应用.四川中医,2007；25(5)：85.
[5]朱玲,罗颂平,许丽绵.左归丸对免疫性卵巢早衰小鼠卵巢Fas、Fas-L表达的影响.江两中医学院学报,2008；20(1)：52-55.
[6]高唱,王景周.左归丸对体外培养新生大鼠海马神经干细胞增殖分化的影响.中国医药学报.2004；19(11)：691-693.
[7]李瀚曼,高翔,晏雪生.左归丸促进骨髓形成肝细胞的研究.世界华人消化杂志,2005；13(24)： 2818-2822.
[8]李瀚曼,张六通,邱幸凡,等.左归丸改善MSG-肝再生-大鼠肝肾精血亏虚证的作用机制研究.湖北中医学院学报,2001；3(4)：30-33.
[9]李瀚曼,晏雪生,罗建君,等.左归丸药物血清对骨髓间质细胞转化为肝细胞的作用.中国组织工程研究与临床康复,2007；28(11)：5465-5468.
[10]鞠大宏,赵宏艳,刘梅洁,等.左归丸含药血清对成骨细胞IL-1、IL-6和COX-2表达的影响.中国实验动物学报,2006；14(2)：96-99.
[11]赵宏艳,鞠大宏,刘梅洁.左归丸含药血清对破骨细胞骨吸收功能的影响以及成骨细胞对其的介导作用.中国中医基础医学杂志,2006；12(9)：662-664.
[12]Mets T, Verdonk G. In vitro aging of human bone marrow-derived stromal cells. Mech Ageing Dev,1981; 16(1):81-89.
[13]Dormady SP, Bashayan 0, Dougherty R, et al. Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res,2001; 10(1): 125-140.
[14]Vlase T, Vlase Gabriela, Doea N. Kineties of thermal decomposition of alkaline phosphates. Journal ofThermal Analysis&Calorimetry,2005; 80(1):207-210.
[15]Pittenger MF, Mackay AM, Beck SC, et al. Muitilineage potential of adult human mesenchymal stem cells. Science,1999; 284(5411):143-147.
[16]李冬菊,葛冬霞,吴文超,等.去卵巢骨质疏松大鼠骨髓间充质干细胞成骨分化能力研究.四川大学学报(医学版),2005；36(3)：318-321.
[17]Ntambi JM, Young-Cheul K. Adipoeyte differentiation and gene expression. J Nutr, 2000; 130(12):3122S-3126S.
[18]李冬菊,李良,吴江,等.去卵巢骨质疏松大鼠骨髓间充质干细胞体外成脂肪分化能力的研究.生物医学工程学杂志,2007；24(3)：641-645.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |